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Abstract
Chimeric kinesin 1 (KHC) / kinesin 5 (Eg5) constructs were used to study the force
generation mechanism of the motor protein. The kinesin family of proteins walk
along microtubules to carry cargo or pull microtubules along each other and do so by
hydrolyzing a single ATP per 8nm step. The mechanism that is employed by kinesin
to generate the force necessary for motion is not completely understood. One recent
model, the cover neck bundle (CNB) model, utilizes two structural elements of the
motor (the coverstrand, which is at the N-terminus of the motorhead) and #9, which is
part of the necklinker (C-terminus of the motorhead) to form a beta sheet. The CNB
folds toward the motor head and causes the rear, unbound head to travel from behind
to in front of the bound motorhead. Recent investigations have shown that the CNB
produces enough force to explain single molecule experiments, and that when the CNB
is not allowed to form by deletion of the coverstrand, the motor looses the ability to
generate force. Recent experiments on dimeric forms of Eg5 (a member of the kinesin 5
family) have shown that the motor is capable of generating nearly analogous amounts
of force as kinesin 1, but that it generally dissociates from the microtubule under
load rather than coming to a true stall. To investigate the applicability of the CNB
model of force generation and to see if a motor with high force capabilities could be
generated, these chimeras employed the Eg5 CNB (and in some cases L13), and the
rest of the kinesin 1 motorhead. It was found from experiments with a stationary
optical trap to measure stall force and the force-velocity relationship of the motors as
well as unloaded measurements, such as processivity and velocity, that motors with a
matched CNB operated the best, however the use of the Eg5 CNB did not reproduce
the force generation capabilities of dimeric Eg5 constructs. These results suggest
that perhaps while the CNB mechanism is very important to force generation, it may
not be the full explanation. A possible link between the CNB's effect on the rate
of the mechanical step of the mechanochemical cycle and the stall force is discussed.
This link between mechanical rate and stall force is a potential avenue for rational
design of kinesin motors for a specific stall force. Secondly, these results show that
the parts of kinesin are not directly interchangeable, and that careful consideration
of the interactions between parts must be considered when engineering these motors.
A second set of experiments were designed to explore whether the CNB mechanism
could be exploited for a rational purpose. The literature consists of many reports of
various methods to target kinesin and stop its motility for therapeutic reason. For
example, some chemotherapies target kinesin to treat cancer. In this way, an antibody
was designed to bind specifically with the coverstrand, thus hopefully disrupting the
CNB formation and mechanism of force generation. These experiments demonstrated
the the antibody was successful in targeting the coverstrand and in inhibiting kinesin's
motion.
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Molecular motors include kinesin, dynein, myosin, the bacterial flagellar motor, poly-
merases, the ribosome, the Clp/Hsp family of proteins and the ATP sythases. Of
these, kinesin, dynein, myosin, and the polymerases are related in that they use
chemical energy from nucleotides (ATP for kinesin, myosin, dynein, and NTPs for
polymerases) [1, 2, 3, 4] to generate force and move along a linear track, micro-
tubules, actin, or DNA and RNA, respectively. Kinesin and dynein both translate
along microtubules, however, there are distinct structural differences between these
two motors, as dynein belongs to the AAA+ family of motors[3]. Kinesin and myosin
have striking similarity with respect to the ATP active site, which is also very similar
to that of the G-proteins (guanine nucleotide-binding proteins) [5].
Molecular motors carry out a great deal of the necessary processes for life. They
allow for the transport of materials within cells such as elements of the cytoskeleton,
and signaling molecules to name a few [6]. Motors are also responsible for cell division
and contraction by allowing motors to pull on cytoskeletal filaments [7, 8]. The
Clp/Hsp proteins are proteases and chaperones that use a motors mechanism to
allow for the degradation or remodeling of protein [9, 10]. In the case of the bacterial
flagella motor, the motor allows for the movement of bacterial cells [11]. Recently,
molecular motors have been suggested for use in nanotechnology applications [12, 13].
1.2 In-vivo duties of kinesin
Kinesin is one of a wide variety of molecular motors that are used by cells for a wide
variety of tasks including organelle movement [6] and mitotic spindle assembly and
organization [7]. Defects in motor-dependent transport are associated with many dis-
eases, including neurodegeneration [14], cancer [15], heart disease [16], developmental
defects [17] and ciliopathies [18]. Directed transport by kinesin allows for the polar-
ization of cells, which would not be possible with simple diffusion [6]. The kinesin
families are localized in cells as shown in figure 1-1.
In-vivo, kinesin transports cargos in complex arrangements with multiple motors.
Multiple copies of kinesin have been found to transport lipid-droplets toward the plus
end of microtubules [19]. It was found that unlike in-vitro findings, in-vioo, cargos are
transported the same distance regardless of the number of copies of kinesin present on
the cargo, and thus a strict regulation of cargo travel must exist in-vivo that doesn't
exist in-vitro. Recently, in-vitro cargos transported by multiples of kinesin have been
found to demonstrate step wise movement with steps sizes that are even fractions of
kinesin's 8nm step [20]. It has also been suggested from in-vitro measurements that
cargos transported by two kinesin generally rely upon the action of only one of the
attached kinesins at a time [21], except under the high force regime. Bidirectional
transport is accomplished via combinations of kinesin and dynein [22]. Combinations
of kinesin and myosin are also utilized for transport of cargos across microtubules and
actin filaments [23, 24].
1.3 Structure of the kinesin family of proteins
A large number of proteins have been found to be part of the kinesin family via genetic
and biochemical approaches [25, 26, 27, 6]. The human genome contains sequences
for 45 kinesins [25]. These motors have a motor domain that is very similar among
the different types of kinesin [28]. The motor domain contains an ATP binding and




Figure 1-1: Localization of the various members of the kinesin family within cells. a)
In neurons plus end directed kinesin transport cargo towards the periphery of the cell
due to polarization of the microtubules to always have the plus end pointing towards
the peripheral edge of the cell. Transport in the cell body is carried out by kinesin 1
(KIF5), kinesin 2 (KIF3), and kinesin 3 (KIF1A, KIF1Ba, KIF1B#, and KIF13B),
which are all plus end directed motors. Within the dendrites of neurons, the polarity
of the microtubules is mixed, and the transport uses kinesin land kinesin 2 (KIF17)
motors. Specifically within dendrites, kinesin 1 is responsible for transport of mRNA-
protein complexes. Kinesin 13 (KIF2A) is involved in microtubule depolymerization
within dendrites. b) Within non-neuronal cells, microtubules are generally organized
such they point to the cell periphery with their plus end, as in neuronal cells. Kinesin
1, kinesin 2, and kinesin 3 (KIFiC, KIF13A, and KIF16B) are used for plus end
directed transport while dynein and kinesin 14B (KIFC2 and KIFC3) are used for
minus end directed transport. Cargos typically contain both plus and minus end
directed motors. c) Intraflegellar transport includes kinesin 2 (KIF3A, KIF3B, and
KIF17 which carry cargos towards the plus end of microtubules, which are oriented
such that the plus end is oriented towards the end of the flagellum. Endoplasmic
reticulum and trans-Golgi network cargos are the major entities being transported
within the flagellum. This figure has been reproduced with permission from [6],
copyright 2009 Macmillan Publishers Limited.
of the motor domain with respect to the ends of the polypeptide chain determines the
directionality of the motor. The majority of kinesin proteins have the motor domain
at the amino terminus (N type), and are microtubule plus end directed. The exception
to this is the Kinesin-13 family (central motor domain motors, M type) and Kinesin-
14 family (carboxy-terminal motors, C type) which have an carboxyl-terminal motor
domain and undergo motility to the minus end of microtubules [6]. Representations
of the members of the kinesin family are shown in figure 1-2. The regions outside the
motor domain are not conserved and are family and function specific. These non-
motor domains include regions that form coiled coils for oligomerization, attachment
to cargo, and regulation [27].
Kinesin is one of the smallest known molecular motors [29], with a size of about 350
amino acids in the motor domain [30]. The other cytoskeleton related motors are much
larger, myosin has approximately 800 amino acids and dynein has over 4,000 [30].
Kinesin constructs may be monomeric, homodimeric, heterodimeric, heterotrimeric,
homotetrameric and heterotetrameric [27]. The structure is broken down into seven a-
helices, ten a-strands, and thirteen loops [31]. The layout of these structural elements
is shown in figure 1-3.
1.4 Overall mechanism of motility
Kinesin takes the chemical energy of ATP and converts it to mechanical energy. It
has been shown that kinesin is able to convert about 50 to 70 percent of the chemical
energy into mechanical work [32, 33]. These efficiencies were able to be estimated
after it was found that kinesin hydrolyzes a single ATP molecule per 8nm step [1].
The exact mechanism regarding the processes by which kinesin carries out its cycle is
still not completely clear, although there has been very significant progress identifying
many of the critical elements. The way in which kinesin takes its steps, how these
steps are regulated (gating), and manner in which kinesin generates force are the
fundamental processes which need to be understood in order to fully understand the











Figure 1-2: Organization of the domains of the members of the kinesin family of
proteins. As can be seen, each member consists of a motorhead domain (large green,
oblong shapes) and a coiled coil domain for oligomerization, except for the monomeric
form of kinesin 3. Generally, the members of the kinesin family also include special
domains that are specific to the motor's cargo binding requirements or regulation.
Many of the motors exist as homodimers (some members of kinesin 2 and kinesin
3, kinesin 4, kinesin 6, kinesin 7, kinesin 8, kinesin 10, kinesin 12, kinesin 13, and
kinesin 14). Kinesin 1 is a heterotetramer with two heavy chains (KHC, containing
the motor domain) and two light chains (KLC). Kinesin 5 (referred to generally as
Eg5 later) is a homotetramer, and acts to crosslink microtubules. The positioning of
the motorhead within the polypeptide chain determines the direction of the motor.
Most of the motors are plus end directed (the motor domain is at the N terminus (N
type), on the left side of the molecule in the diagram), while kinesin 13 has the motor
domain in the middle (M type) and do not have a directional preference, but act to
destabilize microtubules, and kinesin 14 (C type) which are minus end directed. Some
notable departures from the generalizations above include the ability of kinesin 2 to
form heterotetramers (with 2 chains containing motor domains), kinesin 3 to form
monomers, kinesin 9 and 14 can both act to destabilize microtubules, and kinesin
14 can also crosslink microtubules. This figure has been reproduced with permission
from [27], copyright 2009 Macmillan Publishers Limited.
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Figure 1-3: Structural layout of the kinesin 1 motorhead (also largely the same for the
other members of the kinesin family). a) Three-dimensional view of the motorhead
colored to show the segments that are alpha helices (red), beta sheets (yellow), and
loops (green). The coverstrand (0) has been colored magenta, 39 of the necklinker
has been colored blue, and loop 13 (L13) has been colored orange. PDB 1MKJ
was used to generate this figure b) Two-dimensional representation of the layout of
the motor head. Dotted and dashed lines are included for clarity of which elements
the loops connect. The black dashed line surrounds the central beta sheets of the
motorhead. The cyan box surrounded with a red, dashed line highlights the location
of the cover-neck bundle (CNB).
1.4.1 Models of stepping
The kinesin motor has been shown to step in an asymmetric "hand-over-hand" fash-
ion [34]. This motion is identified by a walking motion where the motor heads trade
places with respect to the center of kinesin stalk during the cycle, that is neither of the
heads is always in front of the other, and both heads do not complete the same exact
motion through the cycle. "Inch-worm" movement had also been suggested, which
is where one of the motor heads is always in the front and the other is always in the
back, due to the lack of stalk rotation [35], and the assumption that the cycle would
be symmetric with both motor heads carrying out the same motion. Subsequently,
it was found that the neck stalk (also referred to as the coiled coil) does indeed ro-
tate by 180o in a small fraction of steps [36], although this finding was still able to
be explained by the asymmetric hand-over-hand mechanism. The inch-worm mode
of movement was found to be inconsistent with the finding of "limping" in homod-
imeric kinesin constructs, which is only consistent with asymmetric hand-over-hand
motion [37]. Measurements taken with a singly labelled motor head demonstrated
that the labelled motorhead took 16nm steps [34], which was evidence for either sym-
metric or asymmetric hand-over-hand, thus the only model that was congruent with
all of the reported data was the asymmetric hand-over-hand type of motion.
The reason for kinesin's unidirectional motion has been the subject of great inter-
est. Most members of the kinesin family travel towards the plus end of microtubules,
except for kinesin 15, or NCD. One possible reason for the unidirectional motion
of kinesin is the formation of the cover-neck bundle and the docking of the neck-
linker [29, 38, 39, 40, 41, 42] to the motor head. This process causes the necklinker to
go from unstructured and generally pointing backwards to structured and pointed to-
wards the front of the motor head, thus bringing the rear head forward and the coiled
coil stalk in front of the bound motor head. It was noted that necklinker docking
alone did not provide enough of an energy release to cause a directional preference in
kinesin. Cover-neck bundle formation, which is the formation of a beta sheet between
the coverstrand (30) and the first half of the necklinker (#9) is enough to cause the
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Figure 1-4: Schematic of kinesin's proposed mechanism for motion. The front motor-
head attaches to the microtubule in the empty state. In this state, the motor head is
tilted such that the left side is raised (the lower side is identified by black hatching).
ATP causes the head to rotate and the cover-neck bundle to form thus propelling
the trailing head in front of the bound head. The unbound head looses its ADP,
which allows it to bind to the next microtubule binding site, while the other head
hydrolyzes its ATP to form the ADP-Pj complex. The reverse head looses its organic
phosphate leaving the head in the ADP state and thus releases from the microtubule.
The process then repeats itself for the other head to complete the cycle. Note that
one head passes the bound head on the right and the other passes on the left to form
the asymmetric hand-over-hand walking motion.
0
F7_7175377w h_
forward bias of kinesin [29]. The importance of cover-neck bundle formation was also
shown when the usually minus end directed motor, NCD, was transformed to be a
plus end moving motor with the replacement of its neck domain with that of kinesin
1 [40]. An alternative explanation for the bias of kinesin is that entropy causes a
bias towards forward stepping over backward stepping. This entropy was thought
to arise from affinity changes between the microtubule binding sites and the motor
heads [43]. It was noted that the entropy bias was six times greater than expected for
the necklinker docking model, but this doesn't fully describe why NCD would be able
to reverse direction by changing only the necklinker, as the motor heads are almost
identical to that of kinesin 1. Further, the cover-neck bundle formation model ac-
counts for the ability for directional bias that is not covered by the necklinker docking
model.
1.4.2 Gating of the motorheads
Another great controversy regarding the mechanism of kinesin motion is that of how
the two heads are controlled with respect to each other [37, 3]. Kinesin 1 is a highly
processive motor that can take on the order of hundreds of steps before dissociation
from the microtubule. This fact necessitates that the motors be controlled with regard
to when one may detach from the microtubule and find the next binding site to take a
step. It also remains to be shown why certain members of the kinesin family are very
processive, such as kinesin 1, while others, such as kinesin 5, are much less so [44].
One of the most highly regarded theories of how the heads are coordinated is
though strain built up in the structural elements that link the motor heads, namely the
necklinker and the coiled coil [37]. It was found that the use of non-hydrolyzable ATP
analogs induced kinesin to take backsteps before continuing to walk, which suggested
that strain gated the front head [45]. This finding meant that without hydrolysis, the
only way for the ATP to be released was for the molecule to step back to release the
analog and continue forward stepping. The hypothesis of necklinker mediated gating
was further supported by results obtained with an assay that used the microbead
handle attached to one of the kinesin heads rather than the coiled coil stalk [46], as
is typically done. Here, it was found that kinesin could only adopt a state with two
bound heads when the rear head's necklinker was docked (ATP or ADP-Pj) and the
front head was in a state with an undocked necklinker (no nucleotide or ADP). Single
molecule FRET experiments suggested that the rear head waits behind the front head
in the ADP state [47], which could be reconciled with the previous results by noting
that the FRET data were likely an ensemble average of possible positions, and thus
looked like the unbound head had to stay in a prescribed location [46].
1.4.3 Force Generation
The way in which kinesin generates force has been the subject of much debate. A
model by which the necklinker docked to the motor to form a power stroke was
hypothesized by [42], which was then investigated by thermodynamic means [48]. It
was found that the amount of energy accounted for in the docking of the necklinker
was a small percentage of that available from ATP hydrolysis, and does not account
for the overall efficiency of kinesin, which is approximately 50 percent [37].
A second proposed mechanism for kinesin's ability to generate force is the brown-
ian ratchet, which causes movement rectified by entropy [43]. In this mechanism, the
motor walks by allowing the unbound head to randomly diffuse by brownian motion
until it finds the next microtubule binding location. It was found in [43] that when
the kinesin motility assay was carried out at different temperatures, the number of
forward and backward steps that the motor would take changed. As a result it was
concluded that entropy change associated with binding the next binding location on
the microtubule made it favorable for a the freely diffusing, unbound head to find a
binding spot that carried the molecule towards the plus end of the microtubule. As
pointed out in [37], the mechanisms of a power stroke and the brownian ratchet are
not necessarily exclusive, and that both conformational change and diffusive move-
ment of the motor head likely account for the movement and force generation of
kinesin.
Recently, the cover-neck bundle (CNB) formation model was proposed [29, 38].
In this model, the coverstrand (00) and the first half of the necklinker (09, referred
to as simply the necklinker later) forms a beta-sheet and folds forward to generate
the forward motion and force of the protein. Molecular dynamics simulations showed
that the force generated by the CNB was sufficient to match with experimentally
determined stall forces of kinesin [29]. Fnrther, kinesin constructs lacking the CNB
were unable to generate substantial amounts of force [38]. It is largely believed
that ATP binding to the bound head causes the unbound head to move to the next
microtubule binding location. It was shown with cryo-EM that upon ATP binding,
the kinesin motor head undergoes conformation changes that tilt the head [49] and
allows for CNB formation [39].
1.5 Specific Aims of this thesis
This thesis aims to investigate the theory of CNB formation as the force generation
mechanism of kinesin and ways in which to harness this mechanism for potential
therapeutic means. The CNB model has been tested experimentally with a kinesin
construct that lacked the coverstrand, and thus lacked the ability to form the CNB
as well as a construct that had two glycines mutated into the coverstrand [38]. The
lack of the coverstrand abrogated the ability of the kinesin to generate significant
force, while the construct with glycines allowed for a kinesin that was slightly faster
than the wildtype, and had a stall force that was reduced by about two piconewtons.
The proposed reason for the increase in speed was the increased flexibility of the
coverstrand, and thus a faster formation of the CNB. As will be discussed later, the
glycines may reduced the stability of the CNB, which made it less resistant to force,
thus leading to a lower stall force.
To expand upon these experiments, this thesis demonstrates work done with
chimeric kinesin constructs generated with the coverstrand, necklinker and loop 13
from the kinesin 5 protein, Eg5. The reason for the selection of loop 13 (L13) will be
discussed in chapter 3. These chimeric proteins were examined using laser tweezers
(described in chapter 2) to determine the loaded and unloaded characteristics of the
proteins. This allowed for the determination of the stall force, the velocity as a func-
tion of applied force, kinetic parameters, and run length as a function of structural
make up of the motors. These studies allowed for the elucidation of the relative effects
of each of these structural elements as well as how these elements interact.
A second goal was to determine if the CNB model of kinesin motion could be
harnessed to engineer methods for controlling kinesin motion. Specifically the thesis
addresses wether antibodies targeted towards the coverstrand can stop kinesin from





2.1 Theory of Optical Trapping
Trapping particles with light was first described by [50] where latex particles 2.68pm
could be trapped in the center of a 514.5nm wavelength laser. Later it was shown
that particles ranging in size from 25nm to 10pm could be trapped, which confirmed
that the trap could operate in the Rayleigh regime [51]. Subsequently it was shown
that optical trapping could be extended to biologically relevant specimens, such as
viruses and bacteria [52]. Optical traps have found use in an extremely wide array of
experiments ranging from condensed matter physics to biophysics [53]. An extensive
review of optical trapping theory, methods, instrument design, and experiments can
be found in [54].
The method of treatment used to describe the physics behind the trapping of
dielectric particles varies depending upon the relative size of the particle to the wave-
length of the light used. When the particle is much larger than the wavelength of light
used for illumination, the ray optics model (see figure 2-1) may be used to describe
the action of optical traps. In the ray optics approach, the light refracts as it passes
through the particle, which is generally spherical in the case of biophysical experi-
ments. This refraction causes a change of momentum in the light, as the light exits
the particle. Conservation of momentum dictates that this change in momentum be
accounted for, and results in a force that acts in a direction opposite to the change
in direction of the light due to refraction. The light has a higher intensity near the
center of the laser beam (as is true in the case of a TEMoo mode laser, is generally
correct in practice), thus when the particle is displaced from the center, light that is
refracted from the center of the beam causes a restoring force that pulls the particle
back to the center of the beam. When the particle is in the center of the beam, both
beams are refracted equally and the intensities are symmetric along the face of the
particle that is illuminated, thus the particle stays in the center of the beam. The
force of the light to push the particle in the direction of light propagation is cancelled
by scattering. In reality, the bead comes to equilibrium slightly downstream from the
true waist of the trap, and must be accounted for when calibrating optical trapping
instruments.
F1  F2  F1  F2
Figure 2-1: Explanation of the mechanism of optical trapping with ray optics. The
gaussian beam (signified' by the color bar below each trapped bead image) causes
the light intensity to vary radially (perpendicular to the axis of propagation of the
light) in the beam. When the particle is not in the center of the trap, high intensity
light is refracted towards the outside edge of the trap and the change in moment
creates a strong force that points towards the center of the trap. The lower intensity
light that is refracted towards the center of the trap creates a small force that points
towards the the outside of the trap. The balance of these forces creates a net force
towards the center of the trap. When the particle.is in the center of the trap, the
light is symmetrically refracted by the particle, and there is no net force in the radial
direction, thus causing the particle to remain in the center of the trap.
If the particle is much smaller than the wavelength of light, then electric dipole
approximation may be used. In this model, the particle is treated as a point dipole
in an inhomogeneous electric field. The following mathematical treatment for this









Figure 2-2: Coordinate system and variables of interest in the explanation of the
mechanism of optical trapping in the Rayleigh regime. The z axis points in the
direction of propagation of light, the x axis points in the direction of the electric
polarization. The axis system has its origin at the center of the beam at the beam's
waist. The variable wo is the radius of the beam at the waist, a is the radius of the
particle being trapped, and r is the distance of the particle from the origin.
The scattering force is given by
Fcat(r) = C" (,r ) (2.1)
where z is the distance along the axis of propagation of the laser, n2 is the refractive
index of the surrounding medium, Cpr is the cross section over which the radiation
pressure acts, and 1(r) is the light intensity. The scattering cross section and light
intensity can be substituted to give
Fscat(r) = -- 1r(ka)4a2 (m )2( 2P I exp [ (2.2)i t te p e 1 7rW 1 + (2s)2 1 + (2i)2
where a is the radius of the particle, the normalized spatial coordinates are given
- -- g- 1-Mr - ---- I
by (z, p, 2) = (x/wo, y/wo, z/kw'), k is the wave number in the medium given by
k = 27r/A, and wo is the radius of the beam at the focus.
The force that keeps the particle in the center of the beam, the gradient force is
given by
Fgrad(r, t) = [p(r, t) - V] E(r, t) = 47rnicoa 3 (in 2 +)VE2(r, t) (2.3)2 m2 +2 2
The steady state force experienced by the particle is the time average of the above
equation which results in
27rn2as m 2 _2.4Fgrad(r) = ia 3~VI(r) (2.4)
In practice, the particles trapped for use in single molecule experiments, and indeed
those used in this work, are on the same order of magnitude in size as the wavelength
of the trapping laser (1064nm in this case) and the physics become complicated.
Both ray optics and effects from the Rayleigh regime play a role in explaining the
mechanism for trapping, and the solution to these problems becomes complex to
calculate [56].
2.2 Experimental Instrumentation
The instrument used in the experiments carried out for this thesis utilizes a single
trapping laser and a second laser for position detection. A schematic of the exper-
imental apparatus is shown in figure 2-3. A 1064nn wavelength Nd:YAG laser was
used for trapping. The trapping beam first passed through a zeroth order half wave
plate mounted on a rotational mount. This allows for adjustment of the polarization,
which modulates the strength of the laser beam after the beam passes through a po-
larizing beam splitter cube, the next optic in the beam's path. The beam next travels
through an acousto-optic deflector (AOD), which steers the beam in two dimensions
via scatter from acoustic energy. A rigorous explanation of the operation of AOD's
can be found in [57]. The beam is then expanded by a set of lenses and steered by
another set of lenses before entering the microscope. The set of steering lenses is used
to position the trap such that it appears on the monitors being used for viewing the
microscope's field of view. The difference in beam steering between the AODs and
lenses is that the AODs are used for moving the trapped particle during an experi-
ment while the lenses are used for alignment purposes and are not adjusted during
an experiment. A 975nm wavelength laser is used for particle detection. This laser is
expanded and steered by a set of lenses then introduced into the same set of optics as
the trapping laser with a dichroic mirror. This setup allows for independent x, y, and
z positioning of the beams and combined movement of both beams along the z axis
so that trapped particle can be placed within the focal plane of the microscope and
the particle sits in the detection laser's waist, which as discussed above, is not the
waist of the trapping laser as the particle comes to equilibrium at a location slightly
down stream from the trapping laser's waist. After the beam passes through the op-
tics of the microscope and sample (polarizing filter, Wallaston prism, objective lens,
condenser lens, second Wallaston filter, and the second polarizing filter) the beam
is steered by a dichroic mirror to the detection branch. Here the trapping laser is
filtered out and the detection laser is focused onto a position sensitive device (PSD)
for detection. For all of the experiments conducted here, the fluorescent branch of the
instrument was not used, and illumination was provided by a mercury lamp. Differ-
ential interference contrast microscopy (DIC) was used for viewing the samples. DIC
was necessary for viewing microtubules, which are approximately 20nm in diameter.
2.3 Experimental Assay
Optical traps have been pivotal in the endeavor to understand the mechanism behind
kinesin's motion. The assay used for this work is the classical kinesin motility assay,
shown in figure 2-4. In this assay, kinesin motors are attached to submicron sized
beads via the biotin-avidin interaction. A diffusing bead, which is coated with kinesin,
is captured by the optical trap which is used to place the bead near a microtubule.
When a motor engages the microtubule, it pulls the bead out of the center of the
Figure 2-3: Instrumentation used in this study. a) Schematic of the instrument layout
which shows the optical path of the trapping (1064) and detection lasers (975) as well
as the brightfield illumination system (lamp). The trapping laser is steered with a
two-dimensional acousto-optic deflector (AOD), which is controlled via an amplifier
connected to a computer using LabVIEW for control. The beam is then expanded
and steered with lenses before entering the microscope. Not shown is the zeroth order
wave plate and beam splitting cube which act to attenuate the power of the beam
before entering the AOD. The detection laser is expanded and steered with lenses
before entering the microscope with the trapping laser. After the microscope optics,
the trapping and detection laser enter the detection branch via a dichroic mirror. The
trapping laser is filtered and the detection laser is focused onto a position sensitive
device (PSD) for detection. The PSD's output is sent to a computer for acquisition
via a LabVIEW data acquisition board. b) Photograph of the instrument. One of
the plexiglass panels that cover the trapping and detection optics has been removed
to show the optics. The dark box on the far side of the microscope contains the CCD
cameras and single avalanche photodiode (SAPD) for image or photon collection.
Figure a) has been reproduced with permission from [58], copyright 2006 Biophysical
Society, and b) has been reproduced from the diploma thesis of Benjamin Pelz.
trap until it stalls and detaches from the microtubule. After detachment, the bead
returns to the center of the trap.
Trap VVV
/77-7
Figure 2-4: Schematic of the assay used in this work. The top figure shows the
trapped bead with attached kinesin (not drawn to scale). The kinesin walks along
the microtubule (blue and purple filament), which pulls the bead out of the stationary
trap, thus causing a force to be exerted on the kinesin molecule. The force on the
bead from the trap acts as a Hookean spring, as shown in the bottom figure.
The displacement of the bead is tracked with the use of a second laser that is
used for position detection. The light from the detection laser is captured on a
position sensitive device (PSD), which has a variable output voltage based on bead
position. The voltage output is converted to nanometer space by scanning the bead
and recording the voltage signals as a function of bead position. The output voltages
from the PSD, V1 and V2 are used to obtain the coefficients, a and b for conversion
from voltage to nanometers, by fitting with the following fifth order equations.
5X(V1, V2) == a(jV Vj (2.5)
i,j=O
5
Y (V,IV2) = b = i j V|V| ( 2.6 )
i,j=O
The position sensing system is calibrated so that experiment is performed in the
regime where force is linearly proportional to distance. This makes the trap act
analogous to a Hookean spring. The "spring constant" that is used to convert distance
to force is calculated using the equipartition method
1 1
-kBT = -k((x - X)2) (2.7)2 2
In this method, the bead is trapped and its position is tracked for a short time.
The variance in bead position is then used in the above equation to obtain the trap
stiffness in the x and y axes.
After calibration, the bead is placed near a microtubule for a few seconds to
determine whether the bead has a kinesin motor that will bind to the microtubule
and pull the bead. This process is repeated a total of three times. Experiments in
which approximately 50 percent or less of the beads run are used for analysis.
The unloaded measurements are completed by trapping a bead with kinesin and
testing it for motility, as with the loaded measurements. Instead of leaving the laser on
during the experiment as the bead is pulled by the motor, the trap is shuttered after
the motor takes a couple steps. A CCD camera is used instead of the detection laser
to record the movement of the bead. After the motor releases from the microtubule,
the trapping laser is unshuttered to trap the bead again. The unloaded experiments
were calibrated by replacing ATP with AMP-PNP, a non-hydrolyzable ATP analog.
AMP-PNP causes the kinesin to bind to microtubules but not run. A bead is trapped,
placed next to a microtubule to allow the motor to bind then shuttered. The bead
remains tethered to the microtubule, and the piezo stage is used to move the bead
while the camera captures the movement of the bead. The known displacements of
the bead are used to convert pixels to nanometers. The tracking code is then used




Study of chimeric kinesin
constructs
3.1 Motivation for chimera creation
Chimeras of kinesin 1 and kinesin 5 have been used to elucidate the relative sig-
nificance of the various structural elements in the kinesin motor head. The past
studies done with kinesin I (KHC) / kinesin 5 (Eg5) constructs is shown in ta-
ble 3.1. The necklinker (both 39 and #310), coiled coil, and the elements #38 through
a6 have been investigated previously [59, 60, 61, 62]. New in this study, is the in-
vestigation of the coverstrand (/0 and loop 13 (L13)). In this study, only 39 of
the necklinker was mutated to investigate the importance of the cover neck bun-
dle (CNB). A structural alignment done with PDB structures 1MKJ [63] for ki-
nesin 1 and 2WBE [64] for kinesin 5 using the CE calculate two chains tool (http:
//cl.sdsc.edu/ce/ce-align.html). The two proteins align extremely well, which
can be seen in 3-1. The alignment is extremely good in the regions of interest for
this study, the CS, NL, and L13. Places of diversion include extended loop2 (L2)
and loop4 (L5) and shortened /4, /6, and /7. L5 has been the subject of recent
investigation [65, 61] and is the target of the anticancer drug monastrol [66].
Figure 3-1: Structural alignment of kinesin 1 and kinesin 5 (Eg5). Kinesin 1 is shown
in red and Eg5 in gray. It can be seen that the two structures align very well, especially
in the segments that are of interest for this study, the coverstrand, necklinker, and
L13. The view used here is approximately the same as in 1-3a. Major departures
from alignment in the two proteins happen at loops 2 and 5 as well as in the beta
sheets at the front tip of the motor (#4, #6, and #7).
Table 3.1: Previous studies using kinesin 1 / kinesin 5 chimeras. The construct name, the origin of each the structural element,
a description of the chimera, and the reference from which the chimera originated is provided. The present study is the first to
investigate the effects of the coverstrand and loop 13 (L13). The construct designations, WT, CS, NL, L13, CS-NL, CS-NL-L13,
which are the constructs used in this work will be
Coverstrand Core











































the constructs listed here.
Coiled Coil
K E Notes
X D. melanogaster KHC up
to aa401 (first hinge)
X X. laevis Full length,
tetrameric Eg5 / Up to
aa513, dimer
X K401 with Eg5 CS
X K401 with Eg5 /39
X K401 with Eg5 L13
X K401 with Eg5 CS and #9
X K401 with Eg5 CS, 39,
and L13
X H. sapiens KHC with Eg5
#9, #9, coiled coil
X Eg5 motorhead with H.
sapiens KHC #9, /9,
coiled coil to aa560
X D. melanogaster KHC
with Eg5 coiled coil
X Eg5 with H. sapiens KHC
coiled coil
X H. sapiens KHC up to
middle /9 with Eg5 re-
mainder of /9, 39, coiled
coil to aa513
X H. sapiens KHC up to /8,
Eg5 08 onwards
X Eg5 up to /8, H. sapiens
KHC /8 onwards
X D. melanogaster KHC

















3.2 Chimeras used in this study
The mutations made to the k401 [38, 69] construct are shown in figure 3-2. The
sequences of Drosophila melanogaster kinesin heavy chain (KHC), Homo sapiens ki-
nesin 5 (Eg5), and the resulting chimeras are shown in tables 3.2, 3.3, and 3.4 for
the coverstrand, necklinker (39 only), and L13, respectively. Notable mutations that
the Eg5 sequences bring to kinesin 1 are the mutation from valine to proline in the
necklinker and the mutation from asparagine to arginine in L13. The asparagine in
L13 is highly conserved among a wide range of organisms for kinesin 1.
M A S Q P N
M S A E R E I P A E D S 113
S S A E K G K N 19
M S A K K K E E K G K N I13
(.7
Kinesin I V333 K N V V C V N340 E E L T
Eg5 I 3 59 L N K P E V N3 6 6 Q K - -
Chimera I 359 L N K P E V N34 0 E E L T
Figure 3-2: Identification chimeric sequences used in this study. The fruit fly sequence
of the wildtype protein, the human Eg5 sequence, and the resulting chimeric sequence
for each of the locations of mutations (coverstrand, green; #9, blue; and L13, red) are
shown. The view is similar to that used in figures 1-3a and 3-1. ATP is shown in the







Table 3.2: Sequence comparison for the coverstrand. An alignment was made between human kinesin 1 (KHC), fruit fly KHC,
and human kinesin 5 (Eg5). The isoleucine at the end of the coverstrand is conserved in all of the proteins listed here. It is
interesting to note that the coverstrand is highly variable in length.
* * *
H. sapiens KHC ---- - ----- M A D L A E C N I9
D. melanogaster KHC ------ M S A E R E I P A E D S 1 3
H. sapiens Eg5 M A S Q P N S S A K K K E E K G K N I 19
Table 3.3: Sequence comparison for the fl9 segment of the necklinker. The same
sequence alignment was used as in table 3.2. #9 corresponds to the segment between
the far left isoleucine or valine to asparagine 332 for human KHC (340 for fruit fly
KHC and 365 for human Eg5). Of particular note is the proline residue in Eg5 in
place of the conserved valine in KHC. Proline is known to act as a beta sheet breaker,
thus limiting the size of #9.
*
H. sapiens KHC I32' K N T V C V N332  V E L T
D. melanogaster KHC V333  K N V V C V N340  E E L T
H. sapiens Eg5 159 L N K P E V N36' Q K - -
Table 3.4: Sequence comparison for loop 13 (L13). The same sequence alignment was
used as in table 3.2. Of particular note to L13 is the arginine in Eg5 in place of the
conserved asparagine in the KHC sequences. As can be seen, much of L13 is highly
conserved.
H. sapiens KHC L290 G G N C R295
D. melanogaster KHC L298 G G N A R303
H. sapiens Eg5 L324 G G R T R329
3.3 Kinetic model fits
A number of kinetic mechanisms were considered for fitting including the Boltzmann
(equation 3.1), Fisher two state (equation 3.2), and Three State models(equation 3.3).
The force-velocity data was fit by the three-state model described in [68], equation 3.3.
The Boltzmann model
v(F) Vmax(I+A) (3.1)
1+ Aexp ( F6SkBT,
has been used to model RNA polymerase [4] and kinesin [38] and uses the parameters
Vmax, A, and 6 in the fit. In this model, A is the ratio of time of the mechanical
component of the cycle to the biochemical component (rm/rb) and 6 is the distance
to the transition state. This distance is not necessarily, the step size of the protein,
such as in the case of kinesin. The Fisher two state model [70, 71]
v(F) = d (uoui - wowi) /o-
o~ = UO + U1 + Wo + W1
no = ko[ATP]
u(F) = uexp (-OrFdkBT) (3
0 ko [ATP]
(1 + [ATP]/co) 1/ 2
w(F)= wexp (+0-OFd/kBT)
splits the kinesin's cycle into two states with forward and backward rates, which
results in the cycle being split into four segments each with an associated rate. In
this model, the u terms are forward reaction rates and the w terms are the reverse
rates. The 0 terms are the characteristic fractions of the cycle that are occupied by
each segment. The sum of all four 0 values must equal one. In this model, each of
the four rates are capable of being force dependent. The last model considered for
fitting was the three state model
v(F) k[ dk1 [ATP]k 2 k3k1[ATP] (k2 + k3) + k3 (k2 + k_1 ) (3.3)
k2= ksexp (-F62/kBT)
used in [68]. The rates ki, k_ 1, k2, and k3 are for ATP binding, ATP dissociation,
the mechanical step, and ATP hydrolysis, respectively. k' is the unloaded rate for
the mechanical step and 62 is the characteristic distance to the transition state, as in
the Boltzmann model.
Each of these models was used to fit the data to determine which would provide the
greatest amount of information with simplest form. It was found that the Boltzmann
model and the three state model fit the data with nearly identical curves. Upon
investigation, it was found that the rates of the biochemical (ATP hydrolysis) and
the mechanical step could be extracted from the A value that was fitted by the
Boltzmann model. The time for the biochemical step could be extracted by
Tb 8.2 (3-4)
Vmax(1 + A)
the reciprocal of which is the rate of the biochemical step. The length of the mechan-
ical step was found with
Tm = Arb (3.5)
As with the biochemical step, the reciprocal of this time is the rate of the mechanical
step. When these rates were compared with those that were obtained by the three
state model it was seen that the rates agreed very well. The additional information
that the three state model provided was the rates of ATP binding and dissociation.
These rates were globally fit for all of the chimeras and the wild type motors as it is
assumed that the mutations do not affect the ATP binding domain of the proteins.
This should be a reasonable assumption as the ATP binding domain is located far
from any of the mutated regions. The global fit for the ATP binding and dissoci-
ation constants gave values that were very close to those that had been previously
published [72]. There were great difficulties in using the Fisher two state model for
fitting the data due to the large number of parameters to be fitted (nine parameters),
and the requirement for all of the 0 values to sum to one. For these reasons, the three
state model was selected for fitting the data in this investigation.
3.4 Results
3.4.1 Stall force measurements
Representative runs for the various chimeric kinesin constructs are shown in figure 3-
3. As can be clearly seen, all chimeras take well defined steps of 8nm, and each of
the motors come to a well defined stall. The stall forces obtained by the optical
trapping experiments are shown in figure 3-4. Each of the runs was broken into 15ms
segments in which the average force was measured as well as average velocity, which
was calculated by fitting a line to the position as a function of time data. These
data were used to generate the force-velocity relationships seen in figure 3-5. The
determination of the force-velocity information from stall force data is considered
to be a lower bound [73, 48] because velocities are calculated by assuming that for
each run the velocities above the force where the motor stalls is assumed to be zero.
The force-velocity data was globally fit using the three state model described in the
previous section. The parameters returned by these fits appear in table 3.5. The
stall forces are the mean values plus or minus the standard error of the mean. To
determine whether the chimeric motors indeed stalled or rather released before a true
stall was encountered, the velocity distribution at microtubule release was calculated.
The histograms of velocities at stall for each of the kinesin constructs used in this
study is shown in figure 3-6. The velocities were normalized to the unloaded velocity
of each motor for comparison.
8nm
1OOms
Figure 3-3: Representative traces of runs from each of the constructs used here.
Wildtype is shown in cyan, CS in blue, NL in red, L13 in yellow, CS-NL in brown,
and CS-NL-L13 in turquoise. In each case, the proteins take well defined 8nm steps
have well defined stall plateaus. The scale bars represent 8nm in vertical direction
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Figure 3-4: Stall forces of each of the kinesin constructs used in this study. The
coloring scheme of a) is the same as in figure 3-3. a) Histograms of the stall forces
obtained from stationary trap experiments. As can be seen, each of these distributions
can be fit with a normal distribution (curve) very well. b) The average stall forces for
each of the kinesin constructs. The error bars are plus minus the standard error of the
mean. The wildtype motor produced the most force with a stall force of approximately
5pN, while all of the chimeric proteins produced less force. The numerical values of
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Figure 3-5: The force-velocity behavior of the kinesin constructs used in this study.
The same coloring scheme used here is the same as in figures 3-3 and 3-4a. The
symbols are are the data obtained by mathematical treatment of the stall force data,
as described in the text, except for the velocities at zero force, which were obtained
via the unloaded velocity measurements. The error bars are standard error of the
mean of the data in each force bin. The data was fit with the three state model,
equation 3.3. The unloaded velocities and the data obtained from the stall force
measurements were used in fitting the data.
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Normalized Velocity At Release Normalized Velocity At Release
Figure 3-6: The distributions of velocity at stall from the stall force data. The
distributions are as follows a) WT b) CS c) NL d) L13 e) CS-NL f) CS-NL-L13.
These distributions were obtained by manually fitting a line to time-displacement
data obtained from the stall force measurements to the last few moments before
dissociation. If the slope of this line was negative (backwards motion), the velocity
was assumed to be zero. Each of the distributions was normalized to the unloaded
velocity of the respective motor. As can be seen, these motors all had a sharp peak
in dissociation velocity at very low speeds and the majority of dissociations occurred
below the unloaded velocity.
Table 3.5: Stall force and fitted parameters for force-velocity data for each of the
constructs used in this study. The three state model (equation 3.3 was used to fit the
force-velocity data shown in figure 3-5 to obtain the values shown here. The stall force
is mean plus minus standard error of the mean. The ATP binding and









































































Table 3.6: Unloaded velocities and run lengths for each of the constructs used in this
The data listed is are the average plus






























The unloaded velocities and run lengths of the chimeric kinesin constructs and the
wildtype motor are shown in figure 3-7, and the parameters are shown in table 3.6.
In all cases, the values are averages plus or minus the standard error of the mean.
3.5 Discussion
Kinesin 1 has been been shown in many studies to have a stall force of approximately
5-7pN, an unloaded velocity in the mid hundreds of nanometers per second and a
run length of a few microns [38, 37, 73, 74, 32]. Eg5's motile characteristics are not

















WT CS N L L13 CS-NL CS-NL-L13
Figure 3-7: Unloaded velocities and run lengths for each of the constructs used in
this study. The bars are the average plus or minus the standard error of the mean.
As can be seen, the unloaded velocity was lower for all of the chimeras, but generally
not drastically so. All of the velocities were well above those found for wildtype Eg5
(around 100nm s- 1). The run lengths displayed great variability. The run lengths of
the NL and L13 constructs was approximately that of the construct with a deleted
coverstrand [38]. The presence of the paired coverstrand (CS-NL) and (CS-NL-L13)
recovers some run length, but only to a value about half of the wildtype motor. The
numerical values for these bar plots are shown in table 3.6.
Eg5 in a stationary trap found a stall force of approximately 1.5pN, well below that
of kinesin 1 [67]. In that study it was also found that the tetrameric Eg5 tended
to dissociate from the microtubule before stall. Other studies using truncated con-
structs of Eg5 found that the motor could pull against significantly higher forces. A
truncated form of Eg5 that formed dimers (Eg5-513) was able to walk against forces
in excess of 4pN using a force clanip and that forces at dissociation up to 7pN could
be obtained with the use of a fixed trap [68]. From the run traces shown in that
study, it appeared as though the motor generally dissociated from the microtubule
before coming to a stall. A very recent study has used a kinesin 1 / Eg5 chimera to
study the effect of monasterol on the processive movement of Eg5 [61]. In that study,
the motor was comprised of the Eg5 motorhead lip to the coiled coil. After the Eg5
necklinker, the sequence for kinesin l's coiled coil was used. It was found that this
construct had a dissociation force of 4.6pN, and that again, the motor usually came
off of the microtubule during the run before stalling. It was suggested from that work
that the discrepancy in the force required to dissociate the motor from the micro-
tubule between the dimeric and tetrameric constructs may lie in the C-terminal end
of the Eg5, motor which contains the BimC box, which is highly conserved in Eg5.
Regardless, the reason for the great difference in tetrameric and dimeric constructs
with regards to the force that the motor can withstand is not understood.
It has been recently proposed that the cover neck bundle (CNB), which is the
interaction of the coverstrand (G0) and #9 of the necklinker is the primary mechanism
by which kinesin generates force [29, 38]. This contrasts with previous models in which
force was generated by necklinker docking to the motorhead, which was found to be
slightly thermodynamically favorable [42, 48], however it had been pointed out that it
is unknown how this small thermodynamic favorability would allow the motor to step
against high loads [37] and that the energy accounted for in necklinker docking is a
small fraction of that available from ATP, and it is known that kinesin is at least 50%
efficient. This study aimed to further investigate the plausibility of the CNB model
of force generation, and to possibly develop a kinesin motor that was able to achieve
very high force generating capability by combining kinesin l's ability to stall with
Eg5's ability to generate high forces without stalling. This aim of engineering a more
powerful kinesin motor came with the assumption that the individual parts of proteins
would be interchangeable, and that that the motor's characteristics are a suni of the
contributions from each of the individual components. To test the above hypothesis,
chimeric kinesin 1 / Eg5 constructs were developed that employed all permutations of
the Eg5 CNB as well as the Eg5 L13. L13 was also chosen for investigation, as this loop
sits directly below the CNB, and has been shown in molecular dynamics simulations
to possibly obstruct CNB mediated docking of the necklinker to the motorhead [29].
Further, it was shown in [75] that L13 forms specific contacts with #69. Additionally,
it was shown that mutation of residues in L13 caused severe defects in motility [76].
In that study, the highly conserved glycine residues in L13 were mutated to alanine
(G291A / G292A). It was hypothesized that the reason for the reduced motility was
from a reduction in flexibility in L13 [29]. The location of these mutations is shown
in figures 3-1 and 3-2. A set of seven chimeras were designed, the plasmids generated
(the design and synthesis of the plasmids as well as transformation of the plasmids
into E. coli was done by Matthew Wohlever), expressed in E. coli and purified. Due to
constraints on time, the most important of these were characterized using the kinesin
motility assay described in chapter 2. These constructs included CS, NL, L13, CS-
NL, and CS-NL-L13. The naming of these constructs is such that the signifiers in
the name designate which structural elements the chimera posses from Eg5. The
chimeric sequences for each of the individual components are found in tables 3.2, 3.3,
and 3.4 for the coverstrand, #9 (NL), and L13, respectively. Surprisingly, none of
the chimeric proteins was able to withstand forces as high as the wildtype motor,
and indeed they were below the dissociation forces of the dimeric Eg5 constructs
of [68, 61]. The stall forces generated by these motors are shown in figure 3-4 and
table 3.5 Each of the chimeric motors also had defects in the unloaded velocity and
in unloaded run length (with the exclusion of the CS chimera in terms of unloaded
run length). The unloaded characteristics of the motors is shown in figure 3-7 and
table 3.6. The motors all retained the ability to take 8nm steps and reach full stall,
as shown in figures 3-3 and 3-6.
3.5.1 The role of the coverstrand
The question then becomes why do the chimeras demonstrate reduced functional
properties and what does this information mean for the current models of kinesin
force generation? It appears from the data here and in [38] that the coverstrand
has the ability to affect the velocity of the motor in addition to force generation.
The fact that the Eg5 coverstrand did not affect the motor as greatly as the other
mutations suggest that perhaps the coverstrand, while necessary may not need to be
as specific as the other parts of the protein that were tested. It may be sufficient
that the coverstrand be able to form a beta sheet with #9. Molecular dynamics
simulations [29] suggest that CNB has a conformational bias to move towards the
notorhead and that in crystal structures that are in the ADP state and thus do not
have a formed CNB, when the missing necklinker and coiled coil helix are added,
the same conformational bias of the CNB towards the motor head was seen. The
same sort of "autonomous" behavior was seen here. In this study, when the Eg5
coverstrand was used on an otherwise unmodified motor, the rate of the mechanical
step was slightly reduced, but remained the same order of magnitude. Thus perhaps
that as long as a coverstrand is present to form the CNB, it will fold forward to
generate force. While the coverstrand may appear to be more general than some of
the other parts of the motor, there is evidence that a matched CNB operates more
efficiently. The motors where the coverstrand was matched to the correct 39 (WT
compared to CS and CS-NL compared to NL) had higher stall forces and longer runs
than motors where the coverstrand did not match 09. The unloaded velocity was
not greatly affected by the matching of the coverstrand to #9. This finding is likely
due to the fact that the unloaded velocity of the motor is highly dependent upon the
catalytic rate of the motor (usually referred to as kcat, called k3 in the model used here
for fitting the force-velocity data), and this rate did not differ significantly between
the motors.
3.5.2 The interaction of #9 and L13
As stated above, it has been shown in [75] that the asparagine in the the kinesin
1 L13 interacts with the valine of the necklinker. These two residues are greatly
different in Eg5. The major mutation in the necklinker between kinesin 1 and Eg5
is the substitution of proline for valine. In the case of L13, the major mutation is
arginine for asparagine. The interruption of this contact may explain why the NL
(where the #39 comes from Eg5) and L13 (where L13 comes from Eg5) have the most
drastically reduced performance. This suggestion is supported by a study [76] where
neighboring residues (that are shown to interact in [75]) were mutated to alanine,
which resulted deleterious effects on motor velocity. In that study, the residues that
interact that were modified were N327 and T328 (numbering used for human KHC)
in the necklinker and the two highly conserved glycine residues in L13, which were
mentioned above. When either the NL had the mutations or L13 had the mutations,
it resulted in a 10 and 100 fold, respectively, decrease in microtubule velocity in
a gliding filament assay. Further it was found that the alanine mutations in L13
caused such severe loss of processivity that stall forces could not be measured [77].
Like in this study, [76] found that the catalytic activity of the mutant motors did
not change significantly. Mutant kinesin 1 constructs where the "asparagine latch"
(highly conserved asparagine between #39 and 310 where the necklinker docks to
the motorhead) was mutated to alanine (V331A / N332A, again using human KHC
numbering) showed disruption in the ability to generate force. The mutant was able
to walk against a maximum of 3pN while the wildtype protein in the same study was
able to walk against 4pN of force. The asparagine latch is conserved among both
kinesin 1 and Eg5, and thusly was not mutated in any of the chimeras. Therefore,
none of the reductions in force generating capabilities of the chimeras studied here can
be attributed to defects in the latching action of the asparagine latch. Interestingly,
the NL and L13 chimeras have similar run lengths to the kinesin construct that had
the coverstrand deleted [38]. These chimeras had higher stall forces and unloaded
velocities though. It is possible that these mutations destabilize the CNB or the
(locking of the necklinker to the motorhead which results in defects in the gating
mechanism between the heads. In the case of the Eg5 necklinker, a proline is present,
which is known as a beta sheet breaker. This proline would appear to limit the size
of the CNB, and thus potentially its force generation capability.
3.5.3 L13 as a stabilizer
L13 may act to stabilize the powerstroke when the CNB matches the L13. However
when the CNB does not match the L13, as in the case of when the the Eg5 L13 was
mutated into kinesin lor when the wildtype kinesin 1 L13 was used with the Eg5
CNB, the L13 may act to destabilize the folding of the CNB toward the motorhead.
This is due to the reasons listed above regarding the contacts between .39 and L13.
In the case of the L13 chimera, the arginine residue in place of the asparagine residue
appears to hurt force generation. This might be expected as the Eg5's L13 contains
an arginine in place of an asparagine. The arginine is much larger than the asparagine
and may interfere with the CNB's fold toward the motorhead and the necklinker's
docking to the motorhead. The Eg5 L13 does not appear to significantly affect either
unloaded velocity or run length when used with the Eg5 CNB, but it strikingly
reduced both the unloaded velocity and run length when used with the kinesin 1 CNB.
Interestingly, the characteristic distance for the mechanical step, 62 is lower for the
chimera that contains the mutated coverstrand, #9, and L13 (CS-NL-L13) than the
construct containing the nutated coverstrand and #9 (CS-NL), which would suggest
a decrease in force sensitivity on the mechanical rate (as will be discussed later). In
the three state model, as with the Boltzmann model, the characteristic distance is not
necessarily the full size of the step that the motor takes. The characteristic distance
is usually thought to be less than the step size for kinesin, but in some cases has been
found to be greater than the step size [38].
3.5.4 The structural link to stall force
The characteristic distance caii be thought of as a measure of force sensitivity, as it
is used in the exponential term of the mechanical rate, as seen in equation 3.3. Upon
inspection of the unloaded mechanical rate, it is seen that this rate is an order of
magnitude faster for the CS-NL chimera than the CS-NL-L13 chimera. The unloaded
mechanical rate, ko for the chimeras with a matched CNB are the fastest as stated
above, likely due to fast formation and folding forward of the CNB, however in the
case of the CS-NL chimera, the sensitivity to force is high because the Eg5 L13 is not
present to stabilize the CNB when it folds forward. In the case of CS-NL-L13, the Eg5
L13 may cause CNB folding to be slower, but in the end stabilizes the CNB when it
folds forward, thus producing a less force sensitive mechanical rate. The slower CNB
folding (unloaded mechanical rate), may be the source of the lower stall force. The
slower mechanical rates of these proteins would not significantly affect the velocity of
the motors for most of kinesin's run, as the mechanical rate does not become limiting
until the motor is nearly stalled. Generally, the rate of ATP hydrolysis, k3 is much
slower, and thus limits the velocity of the motors. It is not certain why this might
be the case, but the motors have a mechanical rate of 24 ± 4s- (average plus or
minus the standard deviation) at the stall force. The force at which the mechanical
rate becomes rate limiting (that is, when it becomes slower than the rate of ATP
hydrolysis) is 80 t 3% of the stall force. The consistency of the mechanical rate at
stall and the fraction of the stall force where the mechanical rate becomes limiting
among all of the motor constructs suggests that the mechanical rate and stall force
are closely related. Furthermore, when the data for the constructs where two glycines
were mutated into the coverstrand and where the coverstrand was deleted [38 were
analyzed in this way, it was found that they also had mechanical rates at stall on
the order of tens per second and that the force at which the mechanical rate became
limiting was above 80%. Similar results were also found with the dimeric Eg5 data
of [68, 61]. These results are shown in table 3.7. A hint at the link between the
mechanical rate and the stall force may come from kinesin's dissociation rate from
Table 3.7: Rates for the mechanical step of kinesin's mechanochemical cycle. The
stall force, unloaded mechanical rate and 62 come from table 3.5. The mechanical
rate at stall (kfan were calculated by using the stall force, ko, and 62 for each motor.
The force at which the mechanical step becomes limiting, Fmechlimiting was calculated
by rearranging the second equation in equation 3.3 to solve for force and plugging in
k3 , the catalytic rate, in place of k2.
Fateui (pN) k. (s-') 62 k"l (s1) Fmechumating (pN) Fmechlimiting / Fstai (%)
wT 4.92 18400 5.51 25.40 4.08 82.4
Cs 3.89 6030 5.65 28.86 3.20 82.3
NL 2.95 5150 7.35 26.47 2.45 83.1
L13 2.79 3000 7.27 21.70 2.24 80.2
CS-NL 3.15 13400 8.69 17.23 2.51 79.7
CS-NL-L13 2.78 1690 6.22 25.21 2.10 75.4
2G [38] 3.02 4830 7.15 39.97 2.47 81.8
DEL [38] 1.37 1710 11.28 25.39 1.22 88.8
Eg5 [68] 4.6 [61] 86 1.9 10.28 4.01 87.2
mnicrotubules. It has been found that this dissociation rate is force dependent, and
at forces that are close to these constructs' stall force, the dissociation rate is on
the order of 1s [78]. While this is about an order of magnitude smaller than the
mechanical rate at stall, it may be that the slow mechanical rate at stall allows for a
higher probability of dissociation from the microtubule before the completion of the
full mechanochemical cycle. This link between the mechanical rate of the motor and
the stall force may be a way to rationally engineer kinesin motors to have a prescribed
stall force. By making the CNB fold forward faster (or have less force sensitivity),
it may be possible to make the force at which the mechanical rate becomes limiting
higher, and thus increase the stall force.
3.6 Conclusions
The generation of kinesin 1 / Eg5 chimeras using elements from kinesin's proposed
force generation mechanism, the CNB (the coverstrand and #9) as well as a loop
that is known to interact with 9, L13, have provided additional views into the force
generation mechanism of kinesin. This model has been expanded to include effects
of L13, which appears to have a stabilizing effect, and that this effect is likely due
to contacts between 39 and L13, such as N 327 and T328 of 39 with L290 G291
G292 of L13 (human KHC numbering used) and V329 of #9 with N293 of L13.
Further, by changing the sequences of the components of the CNB and L13, we have
been able to change the rate of the mechanical step. This change in mechanical
rate may be able to explain the differences in stall force that were observed in this
study. The mutation of structural elements of kinesin 1 to that of those containing the
sequences from Eg5 have deleterious effect on kinesin force generation capabilities and
overall performance, even when all of the elements associated with force generation
are mutated to the Eg5 sequences. Comparing these results to the reported force
generating capabilities of dimeric constructs of Eg5 show that while the CNB is
essential, and that a matched CNB works most efficiently, there must be more to the
mechanism of force generation than can simply be explained by the CNB model. It
also illustrates that the parts of kinesin are not directly interchangeable, and that the
behavior of the motor is more than the sum of its parts, but rather the interaction
of these parts with each other in addition to the characteristics of the individual
elements.
It is possible that to capture the force generation characteristics of Eg5, a chimera
including a6, the alpha helix directly preceding #9, needs to also come from Eg5,
and that there is a specific way that a6 operates that is unique to Eg5. a6 has
been shown to form an extra helical turn prior to CNB formation, thus perhaps
the Eg5 CNB requires this part of the Eg5 a6 to operate correctly. A recent study
has formed chimeras using kinesin 1 as the main part of the motorhead and adding
#8, a6, the necklinker and coiled coil from Eg5 [60]. That report showed that the
chimera lost activity, however, they did not use a chimera with the Eg5 coverstrand,
which as shown here, deeply impacts motor performance. A previous study by the
same group [59] also used a chimera that had the Eg5 necklinker with the kinesin
1 motorhead, which they said was not motile. It has been found in this study that
a chimera containing just #9 of the necklinker is indeed motile, although severely
handicapped. Thus, either #10 of Eg5 was further deleterious to activity, or there are
some problems with the chimeric constructs developed by that group.
It could also be plausible that velocity of each motor has an effect on the apparent
stall force. As was very nicely summarized recently [79], the loading rate can markedly
affect the rupture force that is measured between molecules. In this case, with Eg5's
much slower velocity (when compared to kinesin 1), the loading rate is lower, and thus
the stall force that is measured is lower. Under the assumption that the CNB model
is complete, and that motorhead gating is the same in the constructs that contain
the same necklinkers, it is possible that the slower motion of motors such as the L13
chimera causes an apparent decrease in stall force, due to a lower loading rate. Of
course this comes with the caveat that due to dwells that are present in kinesin's
stepping motion, especially at high forces, that the loading rate might actually stay
the same while the velocity appears to have dropped. The methods and future wofk
for addressing these issues are presented in chapter 5.
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Chapter 4
Antibody Inhibition of kinesin
activity
4.1 Motivation for kinesin inhibition
Kinesin is the target for a variety of drugs, specifically agents that target proteins asso-
ciated with mitosis [15, 80, 81, 82, 83, 84, 85]. These drugs are important chemothera-
putic agents to arrest mitosis and cease cell division. While the majority of agents that
target kinesin for cancer therapy are small molecules, antibodies have been shown to
be used to target other proteins in the fight against cancer and other diseases [86, 87].
Antibodies have been generated for targeting kinesin that have the ability to interfere
with kinesin's function [88, 89, 90], however these were not specifically targeted to any
specific structural element of the motorhead. These antibodies were instead simply
raised against the heavy chain. Here we propose to use the CNB mechanism of force
generation to design an antibody that inhibit kinesin's motility.
4.2 Results
The antibodies used for this study were generated by Epitomics, Inc using synthesized
peptides corresponding to the coverstrand of D. melanogaster kinesin 1. Two potential
peptide sequences were used (originally specified by Ricardo Gonzalez Rubio), see
Table 4.1: Sequences of synthetic peptide used for immunization of rabbits for poly-
clonal antibody generation. These sequences correspond to parts of kinesin 1's cov-
erstrand. Version 1 includes the last six residues of the coverstrand plus two glycine
residues and cysteine. The cysteine was added to conjugate the peptide to a sub-
strate for immunization, and the glycine residues were added as flexible peptides.
Version 2 contains all of the residues of the kinesin 1 coverstrand. As with version 1,
a C-terminal cysteine was added for conjugation.
Version I -- ----- P A E D S I G G C
Version 2 M S A E R E I P A E D S I C - -
Table 4.2: Immunization schedule of the four rabbits used for antibody production.
Rabbits were injected with combinations of the peptides shown in table 4.1 four times
to illicit an immune response and produce antibodies specific to these peptides.
Rabbit 07/22/2009 08/12/2009 09/02/2009 09/23/2009
E4078 0.4mg 0.2mg 0.2mg 0.2mg
E4079 Version 1 + Version 1 + Version 1 + Version 1 +
E4080 0.4mg 0.2mg 0.2mg 0.2mg
E4081 Version 2 Version 2 Version 2 Version 2
table 4.1. Version 1 includes less of the sequence of the coverstrand and should
allow for less specific targeting of the coverstrand. The second version covers the full
coverstrand, and was designed so that the antibody would be more specific for the
coverstrand. A cysteine residue was added to the C-terminus of each peptide to attach
the peptides to a substrate for immunization. Four rabbits were immunized with both
version of the peptides with four injections of mixtures of both versions of the peptide
in the schedule shown in 4.2 The version 2 peptide was used for affinity purification of
the antisera. The rabbits were then bled to obtain antisera that was used to determine
which bleeds should be used for antibody purification. It was suggested by Epitomics
that testing either bleeds 1 and 3 or 2 and 4 would be satisfactory for purification
determination. A western blot was run using bleeds 2 and 4 from each of the four
rabbits, which is shown in figure 4-1. From this western blot, it was determined that
bleed 4 from rabbits 4078 and 4080 should be used for purification. The purified sera
was combined and used for all of the experiments described herein.
The western blot showing that the antibody was only specifically targeted to cov-
erstrands with the WT sequence is shown in figure 4-2. The difference in fluorescence
Table 4.3: Bleed schedule for the production of antibodies. The rabbits
four times. Epitomics Inc. sent us the bleeds for determination of which
used for affinity purification. Bleed 0 was taken as a baseline.





E4079 5mL 25mL 25mL 25mL 25mL
E4080 (Bleed 0) (Bleed 1) (Bleed2) (Bleed 3) (Bleed 4)
E4081
d) I e) | f) I g) I h)
Figure 4-1: Western blot used for determination of bleeds to use for purification.
Two bleeds from each of the four rabbits were used, wild type kinesin 1 from D.
melanogaster was used as the target protein. The lanes are as follows a) bleed 2 from
rabbit 4078 b) bleed 2 from 4079 c) bleed 2 from 4080 d) bleed 2 from 4081, e) bleed
4 from 4078 f) bleed 4 from 4079 g) bleed 4 from 4080 h) bleed 4 from 4081. As can
be seen most of the bleeds produced good results, except for the bleeds from rabbit
4081.
of the bands is due to unequal loading of kinesin into the gel used for separating
the protein. Here it is easily seen that only kinesin constructs in which a kinesin 1
coverstrand exists are targeted by the antibody, and thus become fluorescent. The
2G construct, where two glycine residues were mutated into the coverstrand was also
targeted. This was expected as the majority of the residues were the same as the wild
type protein, and that the glycines should make the coverstrand more flexible, and
thus perhaps make the rest of the residues more easily identified by the antibody.
Figure 4-2: Western blot showing the specificity of the antibodies to the kinesin 1
coverstrand of D. melanogaster. Only constructs that contain the wildtype cover-
strand (WT, NL, L13, NL-L13) show targeting. The construct 2G also was targeted
by the antibody, but this was expected as this construct has two residues mutated
to glycine, so the majority of the coverstrand contains the wildtype residues, and the
glycine residues should act to make the coverstrand more flexible, thus potentially
conformally more amenable to detection.
Figure 4-3 shows the concentration dependence on the inhibition of kinesin motion.
In this experiment, the kinesin were incubated with the concentration of antibody to
be tested for fifteen minutes on ice before use. The concentrations of kinesin used in
each of these experiments was slightly above the single molecule limit, where either all
or nearly all beads were motile, but not such high concentrations that the beads would
simply stick to the microtubule and not move in the absence of antibody. Both the
wild type kinesin 1 and CS chimera were used to determine the efficacy of the antibody
to inhibit kinesin motion. Only beads that became tethered to the microtubule after
being placed next to the microtubule for a few seconds were considered for analysis.
Beads that tethered and at some point began running were not considered as being
inhibited. Twenty beads were tested at each concentration of antibody. The CS
chimera was tested with no antibody and with the highest concentration of antibody
that was tested for WT kinesin 1. The CS construct displayed similar motility as in
the unloaded assay described in chapter 3, regardless of the concentration of antibody
that was present. Thus, no antibody related tethering was noticed with the CS
construct, which confirmed that the antibody's effect on kinesin 1's motility is specific
to the antibody binding to the coverstrand and not a nonspecific interaction such as
interaction with the microtubules or glass slide.
4.3 Discussion
The western blot clearly shows that the antibody can target the kinesin constructs
that have the wild type kinesin 1 coverstrand. The concentration dependent inhibition
of kinesin motility was fit using
Y [ AB](41[AB] + KD
where y is the fraction of beads that are not motile, and the pseudo-first order ap-
proxinmation is used. Under the pseudo-first order approximation, the concentration
of ligand (antibody in this case) is assumed to be in a great enough excess that it
can be considered to be constant. The data were also fit with the same relation, but
accounting for antibody depletion with the following formula
(KD + [AB] + [kinesin]) - ,/( KD+ [AR] + [kinesin) 2 - 4[ki nesin] [ AR]
2 [kinesin]
(4.2)
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Figure 4-3: Antibody titration curve, which shows the disruption of kinesin 1's motil-
ity as a function of the concentration of antibody. Only beads that tethered and did
not run at all during the experiment were used for this analysis. The concentration
of kinesin used was slightly above the single molecule limit. Fits to the data included
a model that does not include coopertivity, but uses the pseudo-first order approxi-
mation, where antibody depletion is not accounted for (equation 4.1), a model that
does account for antibody depletion, but not coopertivity (equation 4.2), and a model
that includes the possibility of coopertivity (equation 4.3). The model allowing for
coopertivity fit the data with the highest fidelity. The estimated equilibrium disso-
ciation constant for the coopertivity model was in the low micromolar range with a
coopertivity of nearly two.
Table 4.4: Fit parameters from the antibody titration curve. The two models that
do not allow for coopertivity were nearly identical, showing that antibody depletion
effects were not significant and the pseudo-first order approximation was valid. The
equilibrium dissociation constant found for these noncooperative models was approx-
imately 50nM, which show very good specificity. The coopertivity model fit to a
dissociation constant of about 1.6pM, which shows considerably lower affinity. The
coopertivity was nearly 2, as could be expected for kinesin, which has two coverstrands
per molecule, and thus two binding sites for the antibodies. The coopertivity model
fit the data the best. The low KD could be due to the use of polyclonal antibodies
rather than monoclonal antibodies which would be more specific.
KD (nM) n
Pseudo-first order approximation 50.13 N/A
Accounting for ligand depletion 49.42 N/A
Coopertivity model 1593 1.9
Y [ AB]" 43[AB]"+KD
The parameters determined by these fits are shown in table 4.4. As can be seen
the model that allows for coopertivity fits the data the best, and that the depletion
of antibody is not significant during the experiment, and thus the pseudo-first order
approximation is applicable, as accounting for antibody depletion does not change the
fitted equilibrium dissociation constant, KD. Interestingly, the coopertivity model
suggests that two antibodies can bind to kinesin. This result makes sense as there are
two motor heads per kinesin molecule, and thus two coverstrands per molecule that
can bind antibody. The model that includes coopertivity fits the data most reliably,
which suggests that the antibody does not bind very tightly to kinesin, since it has
a micromolar equilibrium dissociation constant. This is not completely unexpected,
as the antibodies used in this study were polyclonal, and thus less specific than
monoclonal antibodies. Future studies can be conducted with monoclonal antibodies,
which should increase the specificity.
4.4 Conclusions
The antibody binds to the coverstrand and inhibits the ability for kinesin to move.
This appears to be due to the antibody binding to the coverstrand, which then ob-
structs the formation of the cover neck bundle, thus inhibiting the force generation
mechanism of kinesin. It is also known from experiments with the CS chimera, which
is identical to the kinesin 1 construct that was tested except for the coverstrand, that
the antibody's effect on motility is specific to the CNB formation. Further work must
be done to determine the exact mechanism of force generation inhibition in kinesin.
The discussion of these further studies can be found in chapter 5. It is expected that
the antibody binds to the coverstrand and thus sterically inhibits CNB formation. It
is still unknown however, where in the kinesin cycle that the antibody binds to the
coverstrand, and how this affects the ATPase cycle of the motor. It would make sense
that the antibody would interact with the coverstrand in either the empty or ADP
state, as these states correspond to states where the coverstrand is not interacting
with #09. Since the bead appears to tether as soon as it interacts with the micro-
tubule, and that the kinesin was allowed to incubate with the antibodies for some
time before the experiment was started, it is believed that the antibody first binds
to the kinesin in the empty state before interaction with the microtubule. This is
because the empty state is a strong microtubule binder and the ADP state is not.
Chapter 5
Future Work and Directions
5.1 Chimera study
There are a number of further chimeras that can be made to study the motility mech-
anism of kinesin. One such chimera would be to insert the sequence for Eg5's L5 into
kinesin. This loop has been subject of recent investigation [65]. The coverstrand
that was used in this study was the same length of the WT D. melanogaster KHC
coverstrand, which is about ten amino acids shorter than the WT Eg5 coverstrand.
Further chimeras could be generated with the full length Eg5 coverstrand to deter-
mine what the impact of these extra residues. The beta sheet formed between the
coverstrand and #9 is much shorter than the overall length of the coverstrand, so this
chimera may not show significant change in force production, but perhaps the extra
coverstrand length is related to regulation. The coverstrand could also have all of its
residues mutated to alanine. This would determine wether simply having the struc-
tural element is enough for force generation, or if there need to be specific contacts
made between the coverstrand and #9 in order to generate a functional kinesin. To
pursue the goal of a motor that can withstand higher forces than kinesin 1, a chimera
could be generated that uses kinesin l's microtubule binding elements and the rest
of the Eg5 motor to take advantage of the apparent high force capabilities of Eg5
(which are possibly hampered by Eg5's penchant to release before stalling) and the
ability of kinesin 1 to hold on to the microtubule and come to a true stall. One other
possible chimera would one that includes some or all of a6 from Eg5 in addition to
the matching CNB. A recent report has stated that a chimera using a6 from Eg5 in
the context of kinesin 1 was not active, but they did not use the Eg5 CNB, which has
been shown here to be necessary reasonable motor function.
A seemingly simple experiment that could be done to determine the effect of load-
ing rate on kinesin's stall force could be done using a force clamp. Generally, a force
clamp is used to keep a constant force by maintaining a constant offset between the
bead and the trap. Instead of a constant distance, this distance could be modulated
during the experiment to cause the load experienced by the motor to change. Simi-
larly this could be done with a fixed trap that was able to modulate the trap stiffness,
as was done in [4], though instead of changing the trap stiffness to keep a constant
force, this could be changed to produce a desired loading pattern. The effect of the
loading pattern on the observed stall force would allow for the determination of the
role of loading rate on the stall force of kinesin.
Currently on going is a molecular dynamics investigation of the impact of the
mutations on force generation. These simulations are being done in the same manner
as in [29]. The force map of the isolated CNB is being generated for each of the
chimeras. The molecular dynamics simulation will also be extended to include the
L13. From the experimental data generated in this study, it is suggested that L13 can
significantly impact the stall force obtained by the motor, and that this reduction in
force does not appear to be tied to a "force sensor" mechanism in which the motor
dissociates from the microtubule under high force. This is assumed because the
distribution of velocities at release from the microtubule for the constructs where L13
was mutated was very similar to that of the wildtype motor. These simulations will
help to determine if the stall forces found experimentally can be explained by the
CNB model, and to see if there is a way to explain why dimeric Eg5 appears to have
high force capabilities, but the chimeras in this study that make use of the Eg5 CNB
have reduced force generating capabilities.
Table 5.1: Sequences used for the second batch of antibodies. These sequences cor-
respond to the coverstrand of Eg5. Version 1 is the sequence used for the chimeric
kinesin constructs employing the Eg5 coverstrand used in this study. Version 2 is the
full length coverstrand from Eg5. As with the first batch of antibodies, a C-terniinal
cysteine was added for conjugation.
Version 1 ------ M S A K K K E E G K N I C
Version 2 M A S Q P N S S A K K K E E G K N I C
5.2 Antibody Inhibition of kinesin
The antibody generated for this study is specific for the D. melanogaster KHC cover-
strand. We have ordered a new batch of antibodies that are specific to the coverstrand
of H. sapiens Eg5. These new antibodies are being generated to be specific for the
sequences shown in 5.1. Version 1 is specific for the truncated coverstrand used in the
chimeras in this study, and version 2 is specific for the full length Eg5 coverstrand.
This second batch of antibodies is intended to show that the inhibition of kinesin's
motion by targeting the coverstrand is general, and can be applied to motors other
than kinesin 1, as well as showing that the more therapeutically relevant Eg5 motor
can be inhibited by specific antibodies.
The impact of these antibodies can also be studied using ATPase assays to de-
termine how the antibody affects kinesin's mechanochemical cycle. It is currently
unknown if the antibody locks the motor in the empty state, or if the motor can still
bind or hydrolyze ATP while it is attached to the microtubule.
Heterodimers can be generated with one head that has the coverstrand that can
be targeted by the antibody and other other head with a coverstrand that cannot be
targeted. The antibody titration curve that is observed with these heterodimers will
show if there is indeed coopertivity in the binding of antibodies to the motors and
inhibition of motion. It would be expected form the results of this study that in the
case of heterodimers, the coopertivity should disappear, as only one binding site for
the antibody per molecule would be present.
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A.1 Kinesin expression and purification
A.1.1 Materials
1. LB broth (with 100pg/mL ampicillin + 25pug/mL chloraniphenicol)
2. LB agar plates (with 100pg/mL ampicillin + 25pg/mL chloramphenicol)
3. TB broth, Add 47.6g TB (Difco Terrific Broth) and 4niL glycerol into IL deion-
ized water and autoclave. Once cooled add ampicillin, chloramphenicol and
biotin to final concentrations of 100pg/mL, 25pg/mL and 100pM (24mg), re-
spectively.
4. IM IPTG, prepared in water and stored at -20'C
5. Rifampicin, prepared 20mM (16.5mg/mL) in methanol, 100X stock stored at
-200C
6. Lysis buffer, 20mM imidazole, 4mM MgCl 2, pH 7 (0.680g imidazole, 0.408mL
4.9M MgCl 2 for 500nL)
7. #-mercaptoethanol
8. PMSF, (Sigma-Aldrich P7626), 200mM in isopropanol, stored at -20'C
9. Pepstatin A, (Sigma-Aldrich P4265), 5mg/mL in DMSO, stored at -20'C
10. TPCK, (Sigma-Aldrich T4365), 10mg/mL in DMSO, stored at -20'C
11. TAME, (Sigma-Aldrich T4626), 40mg/mL in deionized water, stored at -20'C
12. Leupeptin, (Sigma-Aldrich L9875), 5mg/mL in deionized water, stored at -20'C
13. DNAse I (Sigma-Aldrich D4527), Grade II
14. RNAse A (Sigma-Aldrich R5000), Type II-A
15. Ni-NTA Resin, (Qiagen Ni-NTA Superflow)
16. TCEP, (Molecular Probes T-2566), 10mM in deionized water, prepared fresh
before use
17. Vivaspin 15 spin column, (Vivascience VS1522), 30,000 MWCO
18. Protease Inhibitor Cocktail, PI, prepare 4mL of PI and store at -20'C. Contains:
160pL 0.2mg/mL Pepstatin A, 800pL 2mg/mL TPCK, 200pL 2mg/mL TAME,
160pL 0.2mg/mL Leupeptin, 2muL 2mg/mL Soybean IT, 1880 pL deionized
water
19. Econo-Column Chromatography Columns, (Bio-Rad 737-1512), 1.5xl0cm, 18mL
20. nuPAGE 4-12% Bis-Tris Gels, (Invitrogen NP0321BOX), 1mm x 10 well
21. Kinesin Storage Buffer, 50mM imidazole, 100mM NaCl2, 1mnM MgCl 2 , 20PM
ATP, 0.1mM EDTA, 5% sucrose, pH 7
A.1.2 Day 0
1. Streak fresh colonies on LB-agar plates containing ampicillin and chlorampheni-
col from frozen glycerol stocks stored at -80'C
2. Incubate upside down (agar at the top) at 37'C overnight
A.1.3 Day 1
1. Pick a single colony and add to 20mL of LB (with ampicillin and chlorampheni-
col) in a 250mL flask
2. Shake overnight at 37'C
A.1.4 Day 2
1. Inoculate 500nL of TB broth (with ampicillin and chloramphenicol) with 10mL
of the overnight LB culture
2. Shake at 37'C
3. Induce expression at OD600 = 0.53 - 0.60 by adding IPTG to a final concentra-
tion of 1mM
4. Upon induction, lower shaker temperature to 22'C and shake overnight
A.1.5 Day 3
1. Centrifuge the cells at 5,000g and 4'C for 10 minutes
2. While centrifuging, add #-mercaptoethanol (to a final concentration of 10mM),
1/100 volume of PI, and 1/100 volume of PMSF to lysis buffer to make full lysis
buffer. Make 5nL for each 500mL culture of cells
3. After centrifugation, drain the supernatant and resuspend the pellet in 5mL of
lysis buffer
4. Pipette the resuspended cells into a 15mL centrifuge tube and incubate on ice
for 30 minutes to allow the internal lysozyme to degrade the cell walls
5. Flash freeze the 15mL tube in liquid nitrogen and store overnight at -80'C
A.1.6 Day 4
1. Thaw frozen cells with alternating incubations in a 370C water bath and ice (1
minute in each, do not let the lysate warm up). Once completely thawed, flash
freeze in liquid nitrogen. This process is repeated for a total of three thaws.
After the last thaw, the lysate should be very viscous.
2. Add 500puL 10mg/mL RNAse (final concentration 1mg/mL) and 250pL 10mg/mL
DNAse (final concentration 0.5nig/mL). Incubate on ice for 30 minutes with oc-
casional mixing by inversion. The viscosity should substantially decrease
3. Centrifuge at 21,800g and 4C for 20 minutes and retain the low speed super-
natant. This step pellets out cellular debris
4. Centrifuge at 180,000g and 4C for 30 minutes and retain the high speed super-
natant
5. Add 2mL of Ni-NTA equilibrated in full lysis buffer. To equilibrate Ni-NTA,
wash the resin in full lysis buffer three times by centrifuging at 10,000g and 4'C
for 10 minutes to pellet the resin. Remove supernatant and wash with full lysis
buffer
6. Incubate the resin high speed supernatant mixture at 4C overnight with mixing
by inversion
A.1.7 Day 5
1. Equilibrate the chromatography column by washing with 10mL of full lysis
buffer
2. Prepare 100mL of elution buffer 1 and 2 (elution buffer 1 is the same as lysis
buffer, but with 0-mercaptoethanol, add 7-pL of -mercaptoethanol to 100mL
of lysis buffer). To make elution buffer 2, add 3.268g of imidazole to 100mL of












3. Load Ni-NTA high speed supernatant mixture into the column and collect the
flow through
4. Wash five times with 10mL of lysis buffer
5. After washing, run the imidazole gradient with increasing concentration of im-
idazole
6. Run samples from the flow through, washes, and gradient on an SDS-PAGE
gel to determine which fractions contain kinesin and should be combined. Pool
these fractions
7. Concentrate and buffer exchange the pooled fractions into kinesin storage buffer
with a vivaspin concentrator, centrifuge at 4'C
8. Aliquot the concentrated kinesin solution into 10pL volumes and flash freeze in
liquid nitrogen. Store at -80 C
A.2 Microtubule polymerization
A.2.1 Materials
1. PEM80, 80mM Pipes, imM EGTA, 4mM MgCl 2, pH adjusted to 6.9 with KOH
2. PEM104, 103.6mM Pipes, 13mM EGTA 6.3mM MgCl 2, pH adjusted to 6.9 with
KOH
3. STAB, 34.1pL PEM80, 5pL 10mM GTP stock (Cytoskeleton BST06), 4.7L
60g/L NaN3 , 1.2puL 10mM Taxol stock (Cytoskeleton TXD01), 5pM DMSO
4. Tubulin (Cytoskeleton T237 (now discontinued), replaced with TL238)
A.2.2 Polymerization
1. Centrifuge tubulin aliquot at 10,000g and 4'C for 30 minutes
2. Combine 15.2pL PEM104 and 2tL 10mM GTP to make PEM/GTP
3. Combine 15.2pL PEM/GTP with 2.2pL DMSO and vortex to mix. Add 4.8pL
of 10mg/mL tubulin to make TUB
4. Place TUB in a water bath set to 370C for 30 minutes
5. Remove TUB from the water bath and add 2pL of STAB
6. Store polymerized microtubules at room temperature, NOTE: reconstituted




2. 200 proof ethanol
3. Deionized water
4. Poly-l-lysine solution (Sigma-Aldrich P8920)
A.3.2 KOH Etching
1. Add 100g of KOH pellets to 300mL of ethanol (in a 1,000mL beaker), use a
magnetic stir bar to mix
2. Fill two 1,000mL beakers with 300mL deionized water and one with 300mL of
ethanol
3. Using a bath sonicator, degas all of the solutions for five minutes
4. Place coverslips in teflon racks and immerse one rack at a time in the KOH
solution, sonicate for five minutes
5. Rinse etch slide in one of the beakers of ethanol, then in deionized water
6. Sonicate the rinsed slides in deionized water
7. Rinse slides with deionized water in using a squeeze bottle
8. Rinse slides with ethanol in using a squeeze bottle
9. Dry slides in an oven for 30 minutes
A.3.3 Poly-lysine coating
1. Add 1mL of poly-l-lysine solution to 300mL of ethanol
2. Place a rack of KOH etched coverslides into the poly-lysine ethanol solution
3. Incubate at room temperature for 15 minutes
4. Dry in an oven for 15 minutes
A.4 Kinesin motility assay
A.4.1 Materials
1. PEM80
2. Phosphate buffered saline (PBS)
3. Taxol stock (10mM in DMSO, stored at -20 0C)
4. DTT, 0.5M in 10mM potassium acetate (stored at -20 0C)
5. ATP (100mM in PEM80, stored at -80 0C)
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6. Potassium acetate (3M, stored at 4C)
7. Casein (10mg/mL in PBS with 0.1% tween 20 (PBST), made fresh the day of
the experiment, filtered using a vacuum filter)
8. Kinesin stock (stored at -800C)
9. Streptavidin coated beads
10. Poly-lysine coated KOH etched coverslides
11. Double sided sticky tape
12. Glucose oxidase (10OX stock (Calbiochem 345386), 25mg/mL in PBST, stored
at -800C)
13. fl-D-glucose (10OX stock, 500mg/mL in PBST, stored at -80'C)
14. Catalase (100X stock (Calbiochem 219261), 3mg/mL in PBST, stored at -80'C)
A.4.2 Assay preparation
1. Make PemTax: Add 1,000pL PEM80 and 2pL Taxol, store at room temperature
2. Make assay buffer (AB, final concentrations 0.1mM DTT, 20pM Taxol, 0.2mg/mL
Casein, 1mM ATP, 50mM potassium acetate), store on ice
(a) 2,848pL PEM80
(b) 6pL 0.5M DTT
(c) 6puL 10mM Taxol
(d) 30tL 100mM ATP
(e) 50pL 3M potassium acetate
(f) 60puL 10mg/mL casein
3. Make C-Tax: 80pL PemnTax and 20pL 10mg/mL casein, store on ice
4. Made bead dilutions
(a) Dilute 20pL of 0.44pm streptavidin coated beads into 80pL of PBS
(b) Wash beads five times with PBS by centrifuging at 10,000 RPM for 6
minutes, discarding the supernatant and resuspending in 100pL of PBS
(c) Sonicate the beads twice for two minutes using a cup horn sonicator filled
with water and ice
(d) Make EM/AB by adding 8pL of washed and sonicated beads to 392pL of
AB, store on ice
5. Make kinesin dilutions
(a) K/100: 2pL kinesin stock into 98pL AB (note, this is actually twice as
concentrated as the label suggests, but will be come correct upon adding
beads in subsequent steps)
(b) K/1000: 10pL of K/100 into 90pL AB
(c) Continue diluting in this manner until experiments show that half or less
of the beads move at a given dilution, sometimes K/10 7-8 were necessary.
Store all dilutions on ice
6. Make Kinesin + Bead dilutions (KDB/###)
(a) KDB/100: 50pL EM/AB added to 50pL K/100
(b) Continue making these dilutions for the kinesin concentrations to be tested
(c) Incubate for 1 hour at 4'C
7. Make MT/150 by adding 1pL of polymerized microtubules to 149pL PemTax,
do NOT place on ice
8. Make flow cells for the assay
(a) Place two pieces of double sided tape perpendicular to the long axis of a
thick glass slide
(b) Place a poly-lysine coated coverslide on top of the tape to make a chamber
(c) Flow 15pL of MT/150 and allow to incubate at room temperature for 10
minutes
(d) Wash the chamber with 20pjL of PemTax
(e) Flow in 15pL of C-Tax and incubate at room temperature for 5 minutes
(f) Wash with 50pL of PemTax followed by 8 0pL of AB
(g) Flow in 20pL of the KDB dilution to be assayed
A.4.3 Stall Force Assay
1. Turn on the trapping and detection lasers
2. Turn on the AOD amplifier
3. Load the flow cell slide containing the kinesin sample to be assayed
4. Turn on monitors and camera controller
5. Make adjustments with the microscope (focus, condenser height, filter position)
to image the microtubules and beads
6. Unblock the trapping laser
7. Run the VI to initialize the AODs
8. Test beads for movement
(a) Trap a diffusing bead
(b) Hold the bead near a microtubule for a few seconds, if it moves, go on, if
not, then try the bead on two different microtubules to test for motility
i. For moving beads, run AOD line sweep which is used to align the
AODs with the position detection system. Adjust the micrometers
for the detection branch to bring the AODs and detection branch into
alignment
ii. Once aligned, run the calibration VI, which sets the calibration for con-
version between QPD voltage and nanometer space, as well as running
the calibration for trap stiffness, which uses the variance method
iii. After calibration, start the VI to record the voltage signals from the
VI
iv. Place the bead near a microtubule, as before, and record the movement
of the bead
A.4.4 Unloaded Assay
1. Turn on the trapping and detection lasers
2. Turn on the AOD amplifier
3. Load the flow cell slide containing the kinesin sample to be assayed
4. Turn on monitors and camera controller
5. Make adjustments with the microscope (focus, condenser height, filter position)
to image the microtubules and beads
6. Unblock the trapping laser
7. Run the VI to initialize the AODs
8. Test beads for movement
(a) Trap a diffusing bead
(b) Hold the bead near a microtubule for a few seconds, if it moves, go on, if
not, then try the bead on two different microtubules to test for motility
i. For moving beads, run AOD line sweep which is used to align the
AODs with the position detection system. Adjust the micrometers
for the detection branch to bring the AODs and detection branch into
alignment. This does not have to be as exact as with the stall force
assay, it is just to ensure that the voltage signal used to actuate the
trapping laser's shutter is not anomalous
ii. Place the bead near a microtubule, as before, and run the VI to shutter
the trapping laser after movement of kinesin, the switch that switches
between foot switch actuation and computer actuation needs to be
switched to computer control
iii. Once the bead begins to run, the trapping laser will be shuttered and
the bead will be free to walk on the microtubule. After the bead
dissociates from the microtubule, un-shutter the trapping laser using
the VI and try to recapture the bead for further runs
Appendix B
Code
B.1 Stall Force Data Analysis
B.1.1 Run Analysis
% Before starting program: (1) Make directory called "events"
% (2) Make subdirectories called "stalls" &
% "discards"
function KEval
clear; clc; close all
Vfile = 'QPD Voltage Data.txt'; %Run data
Calfile = 'Fits from fit V to nm.txt'; %21 fit parameters for 5th order fit
StiffFile = 'Variance data for stiffness calibration.txt'; %trace for var
startEvent = 1;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Set MT Direction
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
direct=l; % Either +1 or -1 to make displacements positive
% Threshold force
fcut=0.7;
% Time ahead of the event that is plotted out (sec).
time-ahead = 5;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Read in data
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%Read in for the XY plot version
%Read in data file
tdata=dlmread(Vfile);
lenl=length(tdata(:,1));
tme=2000; % Acquisition rate












% Plot the position data and allow user to select a representative
% baseline segment. Subtract the baseline off so that it is "zeroed"
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
.................. 


















disp('Place cursors to indicate desired regions (BG = Background)');








disp(['Adjusting X baseline by ', num2str(xadj)]);
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% For WT, % this value is 200 nm/s, or roughly 1/2 max. The analysis
% went back 10 % points, or 0.1 sec. This is enough for 1-2 steps to
% occur. For the heterodimer the max velocity will be 20 nm/s, going




%Find points that are above the force and snapback cutoff
releasepoint=(abs(yvel(:))>sncut) & (abs(fdata(1:btnum-1,2))>fcut);





%Readjust the release points to occur at the maximum force near the
%calculated release point (sometimes these seem to occur in the midst of
%a drop (may want to change the force cutoff)




if (ind-fwindow)>0 && (ind+fwindow)<length(releasepoint)
[mxval,mxind]=max(fdata((ind-fwindow):(ind+fwindow),2));
end
if fdata(ind,2) < mxval
releasepoint(ind)=logical(0);

















title(['Force vs. Time - ',Vfile])
axis tight
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Extracting individual peaks.
% Find data where force is above the fcut/2
% Pull data where force is above the fcut/2 and has a release point





pts-behind=floor(.5/dt); %look 5/10ths of a second after
for iCnt=startEvent:length(rpindex)
i-start=af-index(find(af-index<rpindex(iCnt) , 1, 'last') )-pts-ahead;















ecounter (iCnt, 3) =iend;
[FV keep]=EvalEvent(t(i-start: iend) ',rawnmdata(i-start:i-end,
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legend (' X', 'Y')
















xlabel('Stall Force (pN) ')





% Load Calibration Parameters



































%DEG2RAD Converts angles from degrees to radians
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% rad = DEG2RAD(deg) converts angles from degrees to radians.
% See also RAD2DEG, DEG2DMS, ANGLEDIM, ANGL2STR
% Copyright 1996-2000 Systems Planning and Analysis, Inc. and The
% MathWorks, Inc.
% Written by: E. Byrns, E. Brown
% $Revision: 1.8 $ $Date: 2000/01/18 02:00:07 $
if nargin==0
error('Incorrect number of arguments')
elseif -iisreal(D)










% Cursors are specific to a figure. If the figure handle is not specified
% in fighandle, the current figure (returned by gcf) will be used.
% CursorNumber is any positive number. If not specified the lowest numbered
% free cursor number will be used.
% Returns n, the number of the cursor created in the relevant figure.
% A record is kept of the cursors in the figure's application data
% area. Cursor n occupies the nth element of a cell array. Each element is
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% a structure containing the following fields:
% Handles: a list of objects associated with this cursor -
% one line for each axes and one or more text objects
% IsActive: true if this cursor is currently being moved. False
% otherwise. For manual cursors, IsActive is set by a
% button down on the cursor and cleared by a button
% up.
% Functions that affect the position of a cursor must explicitly update all
% the objects listed in Handles. A cursor is not an object itself.
%--
% Author: Malcolm Lidierth 01/07
% Copyright The Author & King's College London 2007
% -
% Note: These functions presently work with 2D views only
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%Dave mod to get around errors with additional arguments in function..








% Get cursor info
newhandles=zeros(l, length(AxesList));
Cursors=getappdata(fhandle, 'VerticalCursors');
% Deal with this cursor number
105






















if -iisempty(Cursors) && -isempty(Cursors{NumberOfCursor}) &&...
isfield(Cursors{NumberOfCursor}, 'CursorIsActive');
if Cursors{NumberOfCursor}.CursorIsActive==true















% For each cursor there is a line object in each axes
subplot(AxesList(i));
YLim=get(AxesList(i),'YLim');
newhandles(i)=line([xhalf xhalf], [YLim(1) YLim(2)]);
Cursors{NumberOfCursor}.Type='2D';
end
% Put a label at the top and make it behave as part of the cursor
axes(AxesList(1));
YLim=get(AxesList(1),'YLim');










% Set line properties en bloc






% Mac etc: 'xor' may cause problems
EraseMode='normal';
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% CursorWindowButtonMotionFcn - figure motion callback to support cursors
% To activate, use
% set(figurehandle, 'WindowButtonMotionFcn',{@CursorWindowButtonMotionFcn})
% This property is set automatically vy CreateCursor
% CursorWindowButtonMotionFcn does not need to be active - if is interferes
% with graphics rendering clear the WindowButtonMotionFcn property
% CursorWindowButtonMotionFcn displays the cursor movement pointer when the
% cursor location is over a line object that belongs to a cursor created by
% CreateCursor. Over a cursor means within 3 pixels of it.
% Note: When the pointer is not over a cursor CursorWindowButtonMotionFcn
% resets the cursor to the default arrow. It will not restore the pointer
% to e.g. an hour glass.
% -------------------------------------------------------------------
% Author: Malcolm Lidierth 01/07































































































































































































































































h=findobj(h, 'Type', 'line','Tag', 'Cursor', 'Parent', gca);
% We may be in the process of deleting the objects or their parents - use
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% only valid handles
h=h(ishandle(h));














%... and get its number
axnumber=whichaxes(pixelpos, coords);
if axnumber==O




% Work on the axes that the pointer is over
ax=AxesList(axnumber);






.... ..... ..... ......
% Current point (axis units)
pos=get(ax,'CurrentPoint');









% Convert to pixels
CursorPos=CursorPos*axpos(3);
pos=pos*axpos(3);
% MATLAB selects an item when the pointer is within 5 pixels.
% Change the pointer when we are within 3 pixels
idx=find(abs(CursorPos(:,1)-pos(l))<3,1);
if -isempty(idx)











function ax = whichaxes(pts,rect)
% whichaxes determines which axes the cursor is over
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....  .. .... ...
% Example:
% ax=whichaxes(pts, rect)
% pts are the cursor coordinates 1x2
% rect are the coordinates for the axes positions Nx4





rect (:,4)=rect (:,2) +rect (:,4);
for k=1:size(rect,1)












% Not so, return and let matlab call the required callback,
% e.g. the uicontextmenu, which will be in the queue
return
end;
% Flag the active cursor
Cursors=getappdata(gcf, 'VerticalCursors');
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% Store these values in the CursorButtonUpFcn persistent variables so they





% Motion callback needs only the current cursor number
CursorButtonMotionFcn({hObject});











% Called from CursorButtonDownFcn - hObject is a cell with values to seed








% Called by button up in a figure window - use the stored CurrentCursor
% value
UpdateCursorPosition(ActiveHandle)
% Restore the figure's original callbacks - make sure we do this in the






















% This replaces the CursorWindowButtonMotionFcn while a cursor is being
% moved
persistent ActiveHandle;





%Called by button up
UpdateCursorPosition(ActiveHandle)
return
% ----- -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
function UpdateCursorPosition(ActiveHandle)
% Get all lines in all axes in the current figure that are




% ... and update them:
% Get the pointer position in the current axes
cpos=get(gca,'CurrentPoint');
if cpos(1,1)==cpos(2,1) && cpos(1,2)==cpos(2,2)
% 2D Cursor













% TODO: Include support for 3D cursors
return
end
% Now update the cursor Label







% SetCursorPos returns the position of a cursor in x-axis units
% Example:
% x=SetCursorLocation(CursorNumber, Position)
% x=SetCursorLocation(fhandle, CursorNumber, Position)
% fhandle defaults to the current figure if not supplied or empty
% Sets the x-axis position for the cursor in the figure
% Author: Malcolm Lidierth 01/07





















%Use try/catch as the selected cursor may not exist
idx=strcmpi(get(Cursors{CursorNumber}.Handles,'type'),'line');



















% fhandle defaults to the current figure if not supplied or empty
% Returns x, the x-axis position for the cursor in the figure
% Author: Malcolm Lidierth 01/07
% Copyright The Author & King's College London 2007































% Author: Malcolm Lidierth 01/07
% Copyright The Author & King's College London 2007








% Retrieve cursor info
Cursors=getappdata(fhandle, 'VerticalCursors');
% Delete associated lines and text
delete(Cursors{CursorNumber}.Handles);
% Empty the cell array element - can be re-used
Cursors{CursorNumber}={};






% Update in application data area
setappdata(fhandle, 'VerticalCursors', Cursors);
function degs=FindMTRotationBoxcar(bcarx,bcary)
% This function assumes you already have filtered your data with a boxcar
% average
% this bizzare thing seems to be a lot happier if we plot x vs y rather









ylabel('Position Y (nm) ')
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cnums(1)=CreateCursor(fh(1),'BG 1',[26/255 133/255 5/255]);
cnums(2)=CreateCursor(fh(1),'BG 2', [26/255 133/255 5/255]);
cnums(3)=CreateCursor(fh(1),'FV 1', [170/255 26/255 5/255]);
cnums(4)=CreateCursor(fh(1),'FV 2', [170/255 26/255 5/255));
% Set cursor positions
% Cursors 3 & 4 get set where the event was detected

















disp(['Place cursors to indicate desired regions (BG = Background, FV'...
' = Force Velocity)']);
input('Hit enter once you are satisfied with your selection');
%Find out the desired positions
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Rotate all of the data (have to do this over, because the baseline may





% Check and plot the variance for the trace - also want to note stall


























set(fh(2),'Position', [100 100 650 800])







title('Event Position vs Time')
axis tight







title('Event Force vs Time')
axis tight














............ ..............................................................................  ................ ......................
ylabel('Velocity (nm/s)')
%text(FV(1,1)+0.05,stallvel+10, ['Force: ',num2str(stallforce),' pN']);
%text(FV(1,1)+0.05,stallvel+32, ['Velocity: ',num2str(stallvel),' nm/s']);
title(['F-V Curve, SF:',num2str(stallforce,2),' pN, SV:',num2str(...
stallvel,2),'nm/s'])
axis tight










keep=input('Keep event? l=yes 2=no: ');
if keep==l
dlmwrite(['.\events\stalls\',savename,'-FV.txt'],FV);
dlmwrite( [' .\events\stalls\',savename, ' -BufferedEvent.txt'), [tdata...
nmdata fdata]);
dlmwrite( ' .\events\stalls\', savename, '_ClippedEvent.txt'),...
[tdata(FStartIndex:FEndIndex) ...
nmdata(FStartIndex:FEndIndex,:) fdata(FStartIndex:FEndIndex,:)]);
save([' .\events\stalls\',savename, ' EventData.mat'], 'event');
disp(['Wrote ',savename,'-... to the \events\stalls directory.'])
else
dlmwrite(['.\events\discards\',savename,'_FV.txt'],FV);
dlmwrite( '.\events\discards\', savename, 'BufferedEvent.txt'], [tdata...
nmdata fdata]);

























% % for i=1:(length(dat)-window+1)
% % sum=O;




















% [s]: time window over which to evaluate
velocities






[VStallsTemp FstallsTemp] = FVRun-v4( Vfile,FBins,sampleRate,...
coppinTime, A ) ;
FStalls = [FStalls FStallsTemp];
VStalls = [VStalls VStallsTemp];
stiff = dlmread(['C:\Documents and Settings\Bill\Desktop\'...
'Research\Kinesin\data\CS\04222010\04222010-CS-E6-4-3.txt']);






.. ...... :::. :::..::: .... . . ..................... ... .... ...............
end
i = 1;





[VStallsTemp FstallsTemp] = FVRun-v4( Vfile,FBins,sampleRate,...coppinTime,a );
FStalls = [FStalls FStallsTemp];
VStalls = [VStalls VStallsTemp];
stiff = dlmread(['C:\Documents and Settings\Bill\Desktop\'...
'Research\Kinesin\data\CS\Loaded-Unloaded test\07212010\'...
'stall-force data\',Vfile(l:length(Vfile)-4),'-3.txt']);








while i < 6
Vfile = ['07232010-CS-1E5-',num2str(i),'.txt'];
cd events;
if exist([Vfile(1:length(Vfile)-4), ' EventIndices.txt'])
cd .. ;
[VStallsTemp FstallsTemp] = FVRun-v4( Vfile,FBins,sampleRate,...
coppinTime,A );
FStalls = [FStalls FStallsTemp];
VStalls = [VStalls VStallsTemp];












while i < 6
Vfile = ['07232010-CS-5E4-',num2str(i),'.txt'];
cd events;
if exist( [Vfile(1:length(Vfile)-4), 'Event-Indices.txt'])
cd ..;
[VStallsTemp FstallsTemp] = FVRun-v4( Vfile,FBins,sampleRate,...
coppinTime,a );
FStalls = [FStalls FStallsTemp];
VStalls = [VStalls VStallsTemp];
stiff = dlmread(['C:\Documents and Settings\Bill\Desktop\'...
'Research\Kinesin\data\CS\Loaded-Unloaded test\07232010\'...
'stall-force data\',Vfile(l:length(Vfile)-4),'-3.txt']);














... . ..................... 
[VStallsTemp FstallsTemp] = FVRun-v4( Vfile,FBins,sampleRate,...
coppinTime,A );
FStalls = [FStalls FStallsTemp];
VStalls = [VStalls VStallsTemp];
stiff = dlmread(['C:\Documents and Settings\Bill\Desktop\'...
'Research\Kinesin\data\CS\Loaded-Unloaded test\07272010\'...
'stall-force data\',Vfile(l:length(Vfile)-4),'-3.txt']);































........... .......... :.: ,.., ... . ..............
;
VStallsTemprow = VStalls(z,:);













% avgV = zeros(size(VStalls,l),l);
% stdevV = zeros(size(VStalls,l),1);
% num = size(VStalls,2);
% for q = 1:size(VStalls,l)
% avgV(q) = mean(VStalls(q,:));










% VBins = zeros(length(FBins),l);
% for i = 1:length(VBins)
% iBins = 0;
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iEvent = iEvent + 1;
VBinsEvent(l:length(FBins),iEvent) = zeros;
cd .. ; cd ..
[VBinsEvent(:,iEvent) FstallsRun(iEvent,1)] = FVEvent-v4...
rawDataFile,FBins,sampleRate,coppinTime,A );
else









% VBinsRun = avgV;




%VBinsRun = VBinsRun ./ iEvent;
%VBinsRun = mean(VBinsRun);
%figure; plot( FBins,VBinsRun,'o');





........................ ................ ............. .
rawData = dlmread( rawDataFile );
tdata = [0:1/sampleRate:(l/sampleRate*(length(rawData)-l))]';




regpts = coppinTime * sampleRate;
iInd=1;













for iBins = 1:length(FBins)
if FBins(iBins)+A/2 < max(Fl)
for j = 1:length(Fl)
if ( Fl(j,l) > 0.25 & Fl(j,1) < FBins(iBins)+A/2) &...
(Fl(j,1) > FBins(iBins)-A/2)
if Vl(j,1) > 0;
VBinsEvent(iBins,1) = VBinsEvent(iBins,l) + Vl(j,1);











for i = 1:length(VBinsEvent)








B.1.3 Velocity at Release




% [s] time wind
%noRuns = input('Largest Run # in Directory?
iRun = 0;






ow over which to evaluate
velocities
')





................................ .................. I .................... ..............
cd .. ;
iRun = iRun + 1;
[VTemp FTemp] = vatstall-run( Vfile,sampleRate );
F = [F FTemp];








while i < 6
Vfile = ['02052010-CS-1E5-',num2str(i),'.txt'];
cd events;
if exist( [Vfile(1:length(Vfile) -4), 'EventIndi
cd .. ;
iRun = iRun + 1;
[VTemp FTemp] = vatstall-run( Vfile,sampleR
F = [F FTemp];










while i < 7




iRun = iRun + 1;
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[VTemp FTemp] = vatstall-run( Vfile,sampleRate );
F = [F FTemp];












iRun = iRun + 1;
[VTemp FTemp] = vatstall-run( Vfile,sampleRate );
F = [F FTemp];








xlabel('Velocity at release (nm/s)')
ylabel('Counts')
figure; hist(F)
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rawData = dlmread( rawDataFile );
tdata = [0:1/sampleRate:(l/sampleRate*(length(rawData)-1))]';









if x(2) > length(nmdata)






F = fdata(length(fdata)-30:length(fdata)); %Average force over 15ms
% (-4 step)
V = pl(l);












.. .... ............. ...... ...........











disp('Pick the corners of the part of the movie to crop')
imshow(ind2gray(v.cdata,v.colormap))
[x y] = ginput(2);
newname = [fname, '-resize.avi'];
aviobj = avifile(newname,'fps',fps);

















pxnm = 30.0295; %pixel to nm conversion, nm/px
check = input(['Create segments or load previously cut segments? 1 for'...
'create 2 for load. ']);
if check == 1
go = 1;
num = 1;
while go == 1
% lind = 1;
% for findex=begin:numframes
% f = aviread(fname,findex);
% imshow(ind2gray(f.cdata,f.colormap))
% title(['frame ',num2str(findex)])
% if lind == 1
% start = input('Start at this frame? 1 for yes 2 for no. ');
% if start == 1
% start = findex;
% lind = 2;
% end
% end
% if lind ==2
% stop = input('End at this frame? 1 for yes 2 for no. ');
% if stop == 1
% stop = findex;





start = input('Enter the frame at which to begin analysis. ');









go = input(['Would you like to create another run segment? 1 for'...




















for findex = 1:numframes
% Step through frame by frame - loading entire avi into memory is not
great since most of these are > 1/2 Gb
fram=aviread(fnametemp,findex);
Spatial Filtering - seems like 20-30 pixels is a good number
bw = im2bw(double(fram.cdata),fram.colormap,0.85); % Binary
bw2 = bwmorph(bw,'majority',Inf); %use this for all other vids
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[L,qty] = bwlabeln(bw2,8); % Label objects on frame
s = regionprops(L, 'Centroid'); % Objects' properties
centrd = cat(1, s.Centroid); % Centroid
ArrayParticle = [1:qty]'; % Object number
DATA-temp.frame = findex; % Frame number
DATA-temp.position = [ArrayParticle, centrd]; % Objects' positions
DATA = [DATA, DATA-temp]; % Accumulate data
x = [x; DATA(1,findex).position(:,2)]; %Creates array that shows x
position of all beads in all frames
y = [y; DATA(1,findex).position(:,3)]; %Creates array that shows x
position of all beads in all frames
%sfram=bpass(fram.cdata,1,25);
Peak finding - want to set a max height to detect at about 70%
of the max height. Looking for objects , 20 pixels in diameter
should drop below if we start seeing multiple objects
imMax=max(max(sfram));
pk=pkfnd(sfram,imMax*0.7,20);
Find the centroid of the blob
Good choice of size is -,2*bpass setting, must be odd
cnt=cntrd (sfram, pk, 45);
disttemp = pxnm*sqrt(((x(findex)-x(1))^2)+((y(findex)-y(1))^2));













vel = [vel; veltemp(l)];
run = [run; dist(length(dist))];




% dlmwrite([fname, '_unloaded.txt'], [vel run])
% plot(bp(:,1),480-bp(:,2)) %Images upper left corner is 0,0 - adjust to
% make these agree
% xlabel('X position (pixels)')
% ylabel('Y position (pixels)')
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